CIRRUS LOGIC INC, 10-K filed on 5/29/2013
Annual Report
Document And Entity Information (USD $)
12 Months Ended
Mar. 30, 2013
May 24, 2013
Sep. 28, 2012
Document And Entity Information [Abstract]
 
 
 
Document Type
10-K 
 
 
Amendment Flag
false 
 
 
Entity Registrant Name
CIRRUS LOGIC INC 
 
 
Entity Central Index Key
0000772406 
 
 
Entity Filer Category
Large Accelerated Filer 
 
 
Entity Well-known Seasoned Issuer
Yes 
 
 
Entity Current Reporting Status
Yes 
 
 
Entity Voluntary Filers
No 
 
 
Document Period End Date
Mar. 30, 2013 
 
 
Document Fiscal Year Focus
2013 
 
 
Document Fiscal Period Focus
FY 
 
 
Current Fiscal Year End Date
--03-30 
 
 
Entity Common Stock, Shares Outstanding
 
63,376,659 
 
Entity Public Float
 
 
$ 1,812,739,022 
Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Mar. 30, 2013
Mar. 31, 2012
Assets
 
 
Cash and cash equivalents
$ 66,402 
$ 65,997 
Marketable securities
105,235 
115,877 
Accounts receivable, net
69,289 
44,153 
Inventories
119,300 
55,915 
Deferred tax assets
64,937 
53,137 
Other current assets
19,371 
16,508 
Total current assets
444,534 
351,587 
Long-term marketable securities
64,910 
2,914 
Property and equipment, net
100,623 
66,978 
Goodwill and intangibles, net
10,677 
24,268 
Deferred tax assets
16,671 
89,071 
Software license agreement
8,060 
 
Other assets
5,872 
9,644 
Total assets
651,347 
544,462 
Liabilities and Stockholders' Equity
 
 
Accounts payable
60,827 
38,108 
Accrued salaries and benefits
16,592 
13,634 
Deferred income
4,956 
7,228 
Supplier agreement
 
5,000 
Other accrued liabilities
10,704 
9,015 
Total current liabilities
93,079 
72,985 
Long-term liabilities
10,094 
5,620 
Stockholders' equity:
 
 
Preferred Stock, 5.0 million shares authorized but unissued
   
   
Common stock, $0.001 par value, 280,000 shares authorized, 63,291 shares and 64,394 shares issued and outstanding at March 30, 2013 and March 31, 2012, respectively
63 
64 
Additional paid-in capital
1,041,771 
1,008,164 
Accumulated deficit
(492,741)
(541,609)
Accumulated other comprehensive loss
(919)
(762)
Total stockholders' equity
548,174 
465,857 
Total liabilities and stockholders' equity
$ 651,347 
$ 544,462 
Consolidated Balance Sheets (Parenthetical) (USD $)
Mar. 30, 2013
Mar. 31, 2012
Consolidated Balance Sheets [Abstract]
 
 
Preferred Stock, shares authorized but unissued
5,000,000 
5,000,000 
Common stock, par value
$ 0.001 
$ 0.001 
Common stock, shares authorized
280,000,000 
280,000,000 
Common stock, shares issued
63,291,000 
64,394,000 
Common stock, shares outstanding
63,291,000 
64,394,000 
Consolidated Statements Of Comprehensive Income (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Mar. 30, 2013
Mar. 31, 2012
Mar. 26, 2011
Consolidated Statements Of Comprehensive Income [Abstract]
 
 
 
Net sales
$ 809,786 
$ 426,843 
$ 369,571 
Cost of sales
414,595 
196,402 
167,576 
Gross margin
395,191 
230,441 
201,995 
Operating expenses:
 
 
 
Research and development
114,071 
85,697 
63,934 
Selling, general and administrative
76,998 
65,208 
58,734 
Patent agreement, net
 
 
(4,000)
Restructuring and other, net
3,292 
 
 
Total operating expenses
194,361 
150,905 
118,668 
Income from operations
200,830 
79,536 
83,327 
Interest income, net
440 
517 
860 
Other income (expense), net
(80)
(70)
27 
Income before income taxes
201,190 
79,983 
84,214 
Provision (benefit) for income taxes
64,592 
(8,000)
(119,289)
Net income
136,598 
87,983 
203,503 
Change in unrealized gain (loss) on marketable securities
(157)
(8)
(105)
Comprehensive income
$ 136,441 
$ 87,975 
$ 203,398 
Basic earnings per share
$ 2.12 
$ 1.35 
$ 3.00 
Diluted earnings per share
$ 2.00 
$ 1.29 
$ 2.82 
Basic weighted average common shares outstanding
64,580 
64,934 
67,857 
Diluted weighted average common shares outstanding
68,454 
68,063 
72,103 
Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Mar. 30, 2013
Mar. 31, 2012
Mar. 26, 2011
Cash flows from operating activities:
 
 
 
Net income
$ 136,598 
$ 87,983 
$ 203,503 
Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Depreciation and amortization
13,562 
9,972 
8,145 
Stock compensation expense
21,495 
12,178 
8,141 
Deferred income taxes
60,600 
(10,154)
(120,045)
(Gain) loss on retirement or write-off of long-lived assets
 
23 
(24)
Excess tax benefit related to the exercise of employee stock options
(106)
 
 
Other non-cash charges
4,792 
 
 
Net change in operating assets and liabilities:
 
 
 
Accounts receivable, net
(25,232)
(5,055)
(15,135)
Inventories
(67,606)
(15,418)
(5,101)
Other assets
134 
(9,783)
(1,158)
Accounts payable
22,423 
10,469 
7,299 
Accrued salaries and benefits
3,260 
1,232 
2,440 
Deferred income
(2,272)
384 
356 
Income taxes payable
263 
(130)
(80)
Other accrued liabilities
(7,087)
1,494 
(1,401)
Net cash provided by operating activities
160,824 
83,195 
86,940 
Cash flows from investing activities:
 
 
 
Proceeds from sale of available for sale marketable securities
127,336 
181,282 
202,753 
Purchases of available for sale marketable securities
(178,847)
(127,852)
(255,426)
Purchases of property, equipment and software
(52,902)
(35,948)
(20,060)
Proceeds from sale of assets
22,220 
 
 
Investments in technology
(3,009)
(6,604)
(1,527)
Decrease in restricted investments
 
5,786 
69 
Decrease (increase) in deposits and other assets
402 
1,773 
(58)
Net cash (used in) provided by investing activities
(84,800)
18,437 
(74,249)
Cash flows from financing activities:
 
 
 
Repurchase and retirement of common stock
(86,059)
(76,782)
(22,766)
Issuance of common stock, net of issuance costs
12,008 
4,108 
31,005 
Repurchase of stock to satisfy employee tax withholding obligations
(1,674)
 
 
Excess tax benefit related to the exercise of employee stock options
106 
 
 
Net cash (used in) provided by financing activities
(75,619)
(72,674)
8,239 
Net increase in cash and cash equivalents
405 
28,958 
20,930 
Cash and cash equivalents at beginning of period
65,997 
37,039 
16,109 
Cash and cash equivalents at end of period
66,402 
65,997 
37,039 
Cash payments during the year for:
 
 
 
Income taxes
$ 5,125 
$ 2,268 
$ 784 
Consolidated Statements Of Stockholders' Equity (USD $)
In Thousands, unless otherwise specified
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Total
Balance at Mar. 27, 2010
$ 66 
$ 952,737 
$ (733,553)
$ (649)
$ 218,601 
Balance, shares at Mar. 27, 2010
65,653 
 
 
 
 
Components of comprehensive income:
 
 
 
 
 
Net income
 
 
203,503 
 
203,503 
Change in unrealized gain on marketable securities
 
 
 
(105)
(105)
Issuance of stock under stock option plans and other, value
31,000 
 
 
31,005 
Issuance of stock under stock option plans and other, shares
4,770 
 
 
 
 
Repurchase and retirement of common stock, value
(2)
 
(22,764)
 
(22,766)
Repurchase and retirement of common stock, shares
(1,759)
 
 
 
 
Amortization of deferred stock compensation
 
8,141 
 
 
8,141 
Balance at Mar. 26, 2011
69 
991,878 
(552,814)
(754)
438,379 
Balance, shares at Mar. 26, 2011
68,664 
 
 
 
 
Components of comprehensive income:
 
 
 
 
 
Net income
 
 
87,983 
 
87,983 
Change in unrealized gain on marketable securities
 
 
 
(8)
(8)
Issuance of stock under stock option plans and other, value
 
4,108 
 
 
4,108 
Issuance of stock under stock option plans and other, shares
642 
 
 
 
 
Repurchase and retirement of common stock, value
(5)
 
(76,778)
 
(76,783)
Repurchase and retirement of common stock, shares
(4,912)
 
 
 
 
Amortization of deferred stock compensation
 
12,178 
 
 
12,178 
Balance at Mar. 31, 2012
64 
1,008,164 
(541,609)
(762)
465,857 
Balance, shares at Mar. 31, 2012
64,394 
 
 
 
 
Components of comprehensive income:
 
 
 
 
 
Net income
 
 
136,598 
 
136,598 
Change in unrealized gain on marketable securities
 
 
 
(157)
(157)
Issuance of stock under stock option plans and other, value
12,006 
 
 
12,008 
Issuance of stock under stock option plans and other, shares
2,025 
 
 
 
 
Repurchase and retirement of common stock, value
(3)
 
(87,730)
 
(87,733)
Repurchase and retirement of common stock, shares
(3,128)
 
 
 
 
Amortization of deferred stock compensation
 
21,495 
 
 
21,495 
Stock compensation expense
 
106 
 
 
106 
Balance at Mar. 30, 2013
$ 63 
$ 1,041,771 
$ (492,741)
$ (919)
$ 548,174 
Balance, shares at Mar. 30, 2013
63,291 
 
 
 
 
Description Of Business
Description Of Business

1.      Description of Business 

 

Description of Business

 

            Cirrus Logic, Inc. (“Cirrus Logic,” “We,” “Us,” “Our,” or the “Company”) develops high-precision, analog and mixed-signal integrated circuits (“ICs”) for a broad range of consumer and industrial markets.  Building on our diverse analog mixed-signal patent portfolio, Cirrus Logic delivers highly optimized products for consumer and professional audio, automotive entertainment, and targeted industrial applications including energy control, energy management, light emitting diode (“LED”) and energy exploration.   

 

            We were incorporated in California in 1984, became a public company in 1989, and were reincorporated in the State of Delaware in February 1999.  Our primary facility housing engineering, sales and marketing, and administration functions is located in Austin, Texas.  In addition, we have sales locations internationally and throughout the United States.  Specifically, we serve customers from international sales offices in Europe and Asia, including the People’s Republic of China, Hong Kong, South Korea, Japan, Singapore, Taiwan, and the United Kingdom.  Our common stock, which has been publicly traded since 1989, is listed on the NASDAQ Global Select Market under the symbol CRUS.

 

Basis of Presentation

 

            We prepare financial statements on a 52- or 53-week year that ends on the last Saturday in March.  Fiscal years 2011 and 2013 were 52-week years, whereas fiscal year 2012 was a 53-week year.

 

Principles of Consolidation

 

            The accompanying consolidated financial statements have been prepared in accordance with U. S. generally accepted accounting principles (U.S. GAAP) and include the accounts of the Company and its wholly-owned subsidiaries.  All significant intercompany balances and transactions have been eliminated.

 

Reclassifications    

 

            Certain reclassifications have been made to prior year balances in order to conform to the current year’s presentation of financial information.

 

Use of Estimates

 

            The preparation of financial statements in accordance with U.S. GAAP requires the use of management estimates.  These estimates are subjective in nature and involve judgments that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at fiscal year-end and the reported amounts of revenue and expenses during the reporting period.  Actual results could differ from these estimates.

Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies

2.      Summary of Significant Accounting Policies

 

Cash and Cash Equivalents

 

            Cash and cash equivalents consist primarily of money market funds, commercial paper, and U.S. Government Treasury and Agency instruments with original maturities of three months or less at the date of purchase

 

Marketable Securities

 

            We determine the appropriate classification of marketable securities at the time of purchase and reevaluate this designation as of each balance sheet date.  We classify these securities as either held-to-maturity, trading, or available-for-sale.  As of March 30, 2013 and March 31, 2012, all marketable securities and restricted investments were classified as available-for-sale securities.  The Company classifies its investments as “available for sale” because it expects to possibly sell some securities prior to maturity.  The Company’s investments are subject to market risk, primarily interest rate and credit risk.  The Company’s investments are managed by an outside professional manager within investment guidelines set by the Company.  Such guidelines include security type, credit quality, and maturity, and are intended to limit market risk by restricting the Company’s investments to high quality debt instruments with relatively short-term maturities.  The fair value of investments is determined using observable or quoted market prices for those securities.

 

            Available-for-sale securities are carried at fair value, with unrealized gains and losses included as a component of accumulated other comprehensive loss.  Realized gains and losses, declines in value judged to be other than temporary, and interest on available-for-sale securities are included in net income.  The cost of securities sold is based on the specific identification method.

 

Inventories 

 

            We use the lower of cost or market method to value our inventories, with cost being determined on a first-in, first-out basis.  One of the factors we consistently evaluate in the application of this method is the extent to which products are accepted into the marketplace.  By policy, we evaluate market acceptance based on known business factors and conditions by comparing forecasted customer unit demand for our products over a specific future period, or demand horizon, to quantities on hand at the end of each accounting period.

 

            On a quarterly and annual basis, we analyze inventories on a part-by-part basis.  Inventory quantities on hand in excess of forecasted demand are considered to have reduced market value and, therefore, the cost basis is adjusted to the lower of cost or market.  Typically, market values for excess or obsolete inventories are considered to be zero.  Product life cycles and the competitive nature of the industry are factors considered in the estimation of customer unit demand at the end of each quarterly accounting period.

 

            Inventories were comprised of the following (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 30,

 

March 31,

 

2013

 

2012

Work in process

$

34,169 

 

$

30,921 

Finished goods

 

85,131 

 

 

24,994 

 

$

119,300 

 

$

55,915 

 

Property, Plant and Equipment, net

 

            Property, plant and equipment is recorded at cost, net of depreciation and amortization.  Depreciation and amortization is calculated on a straight-line basis over estimated economic lives, ranging from three to 39 years.  Leasehold improvements are depreciated over the shorter of the term of the lease or the estimated useful life.  Furniture, fixtures, machinery, and equipment are all depreciated over a useful life of three to 10 years, while buildings are depreciated over a period of up to 39 years.  In general, our capitalized software is amortized over a useful life of three years, with capitalized enterprise resource planning software being amortized over a useful life of 10 years.  Gains or losses related to retirements or dispositions of fixed assets are recognized in the period incurred. 

 

            

 

Property, plant and equipment was comprised of the following (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 30,

 

March 31,

 

2013

 

2012

Land

$

23,778 

 

$

14,059 

Buildings

 

38,257 

 

 

8,351 

Furniture and fixtures

 

9,677 

 

 

4,320 

Leasehold improvements

 

1,091 

 

 

6,765 

Machinery and equipment

 

51,080 

 

 

37,481 

Capitalized software

 

24,671 

 

 

23,459 

Construction in progress

 

2,528 

 

 

28,497 

Total property, plant and equipment

 

151,082 

 

 

122,932 

Less: Accumulated depreciation and amortization

 

(50,459)

 

 

(55,954)

Property, plant and equipment, net

$

100,623 

 

$

66,978 

 

            The increase in the land and buildings balances in fiscal year 2013 was primarily attributable to the construction of the new headquarters facility, which was placed in service during fiscal year 2013, and the purchase of surrounding properties during fiscal year 2013.  Depreciation and amortization expense on property, plant, and equipment for fiscal years 2013, 2012, and 2011 was $10.2 million, $6.3 million, and $4.8 million, respectively. 

 

Goodwill and Intangibles, net

 

            Intangible assets include purchased technology licenses and patents that are reported at cost and are amortized on a straight-line basis over their useful lives, generally ranging from one to ten years.  Acquired intangibles include existing technology, core technology or patents, license agreements, trademarks, covenants not-to-compete and customer agreements.  These assets are amortized on a straight-line basis over lives ranging from four to fifteen years. 

 

            Goodwill is recorded at the time of an acquisition and is calculated as the difference between the aggregate consideration paid for an acquisition and the fair value of the net tangible and intangible assets acquired.  Goodwill and intangible assets deemed to have indefinite lives are not amortized but are subject to annual impairment tests.  If the assumptions and estimates used to allocate the purchase price are not correct, or if business conditions change, purchase price adjustments or future asset impairment charges could be required.  The value of our intangible assets, including goodwill, could be impacted by future adverse changes such as: (i) any future declines in our operating results, (ii) a decline in the valuation of technology company stocks, including the valuation of our common stock, (iii) a significant slowdown in the worldwide economy and the semiconductor industry, or (iv) any failure to meet the performance projections included in our forecasts of future operating results.  The Company tests goodwill and indefinite lived intangibles for impairment on an annual basis or more frequently if the Company believes indicators of impairment exist.  Impairment evaluations involve management estimates of asset useful lives and future cash flows.  Significant management judgment is required in the forecasts of future operating results that are used in the evaluations.  It is possible, however, that the plans and estimates used may be incorrect.  If our actual results, or the plans and estimates used in future impairment analysis, are lower than the original estimates used to assess the recoverability of these assets, we could incur additional impairment charges in a future period.  There are no impairments of goodwill or intangibles in 2013, 2012, and 2011.

 

Long-Lived Assets

 

            We test for impairment losses on long-lived assets and definite-lived intangibles used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets’ carrying amounts.  We measure any impairment loss by comparing the fair value of the asset to its carrying amount.  We estimate fair value based on discounted future cash flows, quoted market prices, or independent appraisals. 

 

Foreign Currency Translation

 

            All of our international subsidiaries have the U.S. dollar as the functional currency.  The local currency financial statements are remeasured into U.S. dollars using current rates of exchange for assets and liabilities.  Gains and losses from remeasurement are included in other income (expense), net.  Revenue and expenses from our international subsidiaries are remeasured using the monthly average exchange rates in effect for the period in which the items occur.  For all periods presented, our foreign currency remeasurement expense was not significant.

 

Concentration of Credit Risk

 

            Financial instruments that potentially subject us to material concentrations of credit risk consist primarily of cash equivalents, marketable securities, long-term marketable securities, and trade accounts receivable.  We are exposed to credit risk to the extent of the amounts recorded on the balance sheet.  By policy, our cash equivalents, marketable securities, and long-term marketable securities are subject to certain nationally recognized credit standards, issuer concentrations, sovereign risk, and marketability or liquidity considerations.

 

            In evaluating our trade receivables, we perform credit evaluations of our major customers’ financial condition and monitor closely all of our receivables to limit our financial exposure by limiting the length of time and amount of credit extended.  In certain situations, we may require payment in advance or utilize letters of credit to reduce credit risk.  By policy, we establish a reserve for trade accounts receivable based on the type of business in which a customer is engaged, the length of time a trade account receivable is outstanding, and other knowledge that we may possess relating to the probability that a trade receivable is at risk for non-payment. 

 

            For fiscal year 2013, we had three contract manufacturers, Futaihua Industrial, Hongfujin Precision and Protek, who represented 21 percent, 36 percent, and 16 percent of our consolidated gross accounts receivable, respectively.  In fiscal year 2012, we had two contract manufacturers, Futaihua Industrial and Hongfujin Precision, who represented 28 percent and 14 percent, respectively, of our consolidated gross accounts receivable.  No other distributor or customer had receivable balances that represented more than 10 percent of consolidated gross accounts receivable as of the end of fiscal year 2013 or 2012.

 

            Since the components we produce are largely proprietary and generally not available from second sources, we consider our end customer to be the entity specifying the use of our component in their design.  These end customers may then purchase our products directly from us, from a distributor, or through a third party manufacturer contracted to produce their end product.  For fiscal years 2013, 2012, and 2011, our ten largest end customers represented approximately 89 percent, 74 percent, and 62 percent of our sales, respectively.  For fiscal years 2013, 2012, and 2011, we had one end customer, Apple Inc., who purchased through multiple contract manufacturers and represented approximately 82 percent, 62 percent, and 47 percent of the Company’s total sales, respectively.  Further, we had one distributor, Avnet, Inc., that represented 15 percent, and 24 percent of our sales for fiscal years 2012, and 2011, respectively.    No other customer or distributor represented more than 10 percent of net sales in fiscal years 2013, 2012, or 2011.

 

Revenue Recognition

 

            We recognize revenue when all of the following criteria are met: persuasive evidence that an arrangement exists, delivery of goods has occurred, the sales price is fixed or determinable and collectability is reasonably assured.  We evaluate our distributor arrangements, on a distributor by distributor basis, with respect to each of the four criteria above.  For a majority of our distributor arrangements, we provide rights of price protection and stock rotation.  As a result, revenue is deferred at the time of shipment to our domestic distributors and certain international distributors due to the determination that the ultimate sales price to the distributor is not fixed or determinable.  Once the distributor has resold the product, and our final sales price is fixed or determinable, we recognize revenue for the final sales price and record the related costs of sales.  For certain of our smaller international distributors, we do not grant price protection rights and provide minimal stock rotation rights.  For these distributors, revenue is recognized upon delivery to the distributor, less an allowance for estimated returns, as the revenue recognition criteria have been met upon shipment. 

 

            Further, the Company defers the associated cost of goods sold on our consolidated balance sheet, net within the deferred income caption.  The Company routinely evaluates the products held by our distributors for impairment to the extent such products may be returned by the distributor within these limited rights and such products would be considered excess or obsolete if included within our own inventory.  Products returned by distributors and subsequently scrapped have historically been immaterial to the Company.

 

Warranty Expense

 

            We warrant our products and maintain a provision for warranty repair or replacement of shipped products.  The accrual represents management’s estimate of probable returns.  Our estimate is based on an analysis of our overall sales volume and historical claims experience, and the sales volume and historical claims experience at our largest customer, Apple, Inc.  The estimate is re-evaluated periodically for accuracy.

 

Shipping Costs

 

            Our shipping and handling costs are included in cost of sales for all periods presented in the Consolidated Statements of Comprehensive Income.

 

Advertising Costs

 

            Advertising costs are expensed as incurred.  Advertising costs were $1.5 million, $1.8 million, and $1.3 million, in fiscal years 2013, 2012, and 2011, respectively.

 

Stock-Based Compensation

 

            Stock-based compensation is measured at the grant date based on the grant-date fair value of the awards and is recognized as an expense, on a ratable basis, over the vesting period, which is generally between zero and four years.  Determining the amount of stock-based compensation to be recorded requires the Company to develop estimates used in calculating the grant-date fair value of stock options.  The Company calculates the grant-date fair value for stock options using the Black-Scholes valuation model.  The use of valuation models requires the Company to make estimates of assumptions such as expected volatility, expected term, risk-free interest rate, expected dividend yield, and forfeiture rates.  The grant-date fair value of restricted stock units is the market value at grant date multiplied by the number of units. 

 

Income Taxes

 

            We provide for the recognition of deferred tax assets if realization of such assets is more likely than not.  The Company evaluates the ability to realize its deferred tax assets based on all the facts and circumstances, including projections of future taxable income and expiration dates of carryover attributes on a quarterly basis.  We have provided a valuation allowance against a portion of our net U.S. deferred tax assets due to uncertainties regarding its realization.  The calculation of our tax liabilities involves assessing uncertainties with respect to the application of complex tax rules and the potential for future adjustment of our uncertain tax positions by the Internal Revenue Service or other taxing jurisdiction.  We recognize liabilities for uncertain tax positions based on the two-step process.  The first step requires us to determine if the weight of available evidence indicates that the tax position has met the threshold for recognition; therefore, we must evaluate whether it is more likely than not that the position will be sustained on audit, including resolution of any related appeals or litigation processes.  The second step requires us to measure the tax benefit of the tax position taken, or expected to be taken, in an income tax return as the largest amount that is more than 50 percent likely of being realized upon ultimate settlement.  We reevaluate the uncertain tax positions each quarter based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, expirations of statutes of limitation, effectively settled issues under audit, and new audit activity.  If our estimates of these taxes are greater or less than actual results, an additional tax benefit or charge will result. 

 

            Although we believe the measurement of our liabilities for uncertain tax positions is reasonable, no assurance can be given that the final outcome of these matters will not be different than what is reflected in the historical income tax provisions and accruals.  If additional taxes are assessed as a result of an audit or litigation, it could have a material effect on our income tax provision and net income in the period or periods for which that determination is made.  We operate within multiple taxing jurisdictions and are subject to audit in these jurisdictions.  These audits can involve complex issues which may require an extended period of time to resolve and could result in additional assessments of income tax. We believe adequate provisions for income taxes have been made for all periods.

 

Net Income Per Share

 

            Basic net income per share is based on the weighted effect of common shares issued and outstanding and is calculated by dividing net income by the basic weighted average shares outstanding during the period.  Diluted net income per share is calculated by dividing net income by the weighted average number of common shares used in the basic net income per share calculation, plus the equivalent number of common shares that would be issued assuming exercise or conversion of all potentially dilutive common shares outstanding.  These potentially dilutive items consist primarily of outstanding stock options and restricted stock awards.

 

            The following table details the calculation of basic and diluted earnings per share for fiscal years 2013, 2012, and 2011 (in thousands, except per share amounts):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Numerator:

 

 

 

 

 

 

 

 

Net income

$

136,598 

 

$

87,983 

 

$

203,503 

Denominator:

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

64,580 

 

 

64,934 

 

 

67,857 

Effect of dilutive securities

 

3,874 

 

 

3,129 

 

 

4,246 

Weighted average diluted shares

 

68,454 

 

 

68,063 

 

 

72,103 

Basic earnings per share

$

2.12 

 

$

1.35 

 

$

3.00 

Diluted earnings per share

$

2.00 

 

$

1.29 

 

$

2.82 

   

            The weighted outstanding options excluded from our diluted calculation for the years ended March 30, 2013, March 31, 2012, and March 26, 2011, were 453,000,  1,052,000,  and 615,000, respectively, as the exercise price exceeded the average market price during the period.

 

Accumulated Other Comprehensive Loss

 

            Our accumulated other comprehensive loss is comprised of foreign currency translation adjustments from prior years when we had subsidiaries whose functional currency was not the U.S. Dollar, as well as unrealized gains and losses on investments classified as available-for-sale.  See Note 16 – Accumulated Other Comprehensive loss for additional discussion.

 

Recently Issued Accounting Pronouncements

 

            In July 2012, the FASB issued ASU No. 2012-02, Intangibles – Goodwill and Other (ASC Topic 350) – Testing Indefinite-Lived Intangible Assets for Impairment.  With the amendments in this update, an entity has the option to first assess qualitative factors to determine whether it is more likely than not that indefinite-lived assets, other than goodwill, are impaired.  If, after the assessment, an entity concludes it is not more likely than not that the asset is impaired, then the entity is not required to assess further.  If an entity concludes otherwise, the fair value determination and quantitative impairment test is required, in accordance with Subtopic 350-30.  The amendments in this ASU are effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012, with early adoption permitted.  The adoption of this ASU is not expected to have a material impact on our consolidated financial position, results of operations or cash flows.

 

            In February 2013, the FASB issued ASU No. 2013-02, Comprehensive Income (ASC Topic 220) –Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income.  With the amendments in this update, an entity is required to “report the effect of significant reclassifications out of accumulated other comprehensive income on the respective line items in net income if the amount being reclassified is required under U.S. GAAP to be reclassified in its entirety to net income.  For other amounts that are not required under U.S. GAAP to be reclassified in their entirety to net income in the same reporting period, an entity is required to cross-reference other disclosures required under U.S. GAAP that provide additional detail about those amounts.”  The amendments in this ASU are effective prospectively for reporting periods beginning after December 15, 2012, with early adoption permitted.  We began complying with this ASU, as defined, in fiscal year 2013 and the adoption of this ASU currently does not, and is not expected to have a material impact on our consolidated financial position, results of operations or cash flows.

Marketable Securities
Marketable Securities

3.      Marketable Securities

 

            The Company’s investments that have original maturities greater than 90 days have been classified as available-for-sale securities in accordance with U.S. GAAP.  Marketable securities are categorized on the consolidated balance sheet as marketable securities, as appropriate.

 

            The following table is a summary of available-for-sale securities (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Estimated

 

 

 

 

 

Gross

 

 

Gross

 

 

Fair Value

 

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

(Net Carrying

As of March 30, 2013

 

Cost

 

 

Gains

 

 

Losses

 

 

Amount)

Corporate debt securities

$

94,798 

 

$

 

$

(133)

 

$

94,667 

U.S. Treasury securities

 

34,380 

 

 

 

 

(3)

 

 

34,381 

Agency discount notes

 

1,027 

 

 

 -

 

 

 -

 

 

1,027 

Commercial paper

 

40,089 

 

 

 

 

(28)

 

 

40,070 

Total securities

$

170,294 

 

$

15 

 

$

(164)

 

$

170,145 

 

            The Company’s specifically identified gross unrealized losses of $164 thousand relates to 43 different securities with a total amortized cost of approximately $124.1 million at March 30, 2013. Because the Company does not intend to sell the investments at a loss and the Company will not be required to sell the investments before recovery of its amortized cost basis, it did not consider the investment in these securities to be other-than-temporarily impaired at March 30, 2013.  Further, the securities with gross unrealized losses had been in a continuous unrealized loss position for less than 12 months as of March 30, 2013.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Estimated

 

 

 

Gross

 

Gross

 

Fair Value

 

Amortized

 

Unrealized

 

Unrealized

 

(Net Carrying

As of March 31, 2012

Cost

 

Gains

 

Losses

 

Amount)

Corporate debt securities

$

48,011 

 

$

33 

 

$

(19)

 

$

48,025 

U.S. Treasury securities

 

30,264 

 

 

 

 

(4)

 

 

30,261 

Agency discount notes

 

16,789 

 

 

 

 

(1)

 

 

16,796 

Commercial paper

 

23,719 

 

 

 

 

(15)

 

 

23,709 

Total securities

$

118,783 

 

$

47 

 

$

(39)

 

$

118,791 

 

            The Company’s specifically identified gross unrealized losses of  $39 thousand relates to 37 different securities with a total amortized cost of approximately $72.6 million at March 31, 2012.  Because the Company does not intend to sell the investments at a loss and the Company will not be required to sell the investments before recovery of its amortized cost basis, it did not consider the investment in these securities to be other-than-temporarily impaired at March 31, 2012.  Further, the securities with gross unrealized losses had been in a continuous unrealized loss position for less than 12 months as of March 31, 2012.

 

The cost and estimated fair value of available-for-sale investments by contractual maturity were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 30, 2013

 

 

March 31, 2012

 

 

 

Amortized

 

 

Estimated

 

 

Amortized

 

 

Estimated

 

 

 

Cost

 

 

Fair Value

 

 

Cost

 

 

Fair Value

Within 1 year

 

$

105,290 

 

$

105,235 

 

$

115,871 

 

$

115,876 

After 1 year

 

 

65,004 

 

 

64,910 

 

 

2,912 

 

 

2,915 

Total

 

$

170,294 

 

$

170,145 

 

$

118,783 

 

$

118,791 

 

Fair Value Of Financial Instruments
Fair Value Of Financial Instruments

4.      Fair Value of Financial Instruments

 

The Company has determined that the only assets and liabilities in the Company’s financial statements that are required to be measured at fair value on a recurring basis are the Company’s investment portfolio assets. The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.  The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

 

 

 

 

 

 

 

Level 1 — Quoted prices in active markets for identical assets or liabilities.

 

 

 

 

 

 

Level 2 — Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

 

 

 

 

 

Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

 

The Company’s investment portfolio assets consist of corporate debt securities, money market funds, U.S. Treasury securities, obligations of U.S. government-sponsored enterprises, and commercial paper, and are reflected on our consolidated balance sheet under the headings cash and cash equivalents, marketable securities, and long-term marketable securities.  The Company determines the fair value of its investment portfolio assets by obtaining non-binding market prices from its third-party portfolio managers on the last day of the quarter, whose sources may use quoted prices in active markets for identical assets (Level 1 inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in determining fair value. 

 

As of March 30, 2013 and March 31, 2012, the Company classified all investment portfolio assets as Level 1 or Level 2 assets.  The Company has no Level 3 assets.  There were no transfers between Level 1, Level 2, or Level 3 measurements for the years ending March 30, 2013 and March 31, 2012.

 

The fair value of our financial assets at March 30, 2013, was determined using the following inputs (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quoted Prices

 

 

 

 

 

 

 

in Active

 

Significant

 

 

 

 

 

Markets for

 

Other

 

Significant

 

 

 

Identical

 

Observable

 

Unobservable

 

 

 

Assets

 

Inputs

 

Inputs

 

 

 

Level 1

 

Level 2

 

Level 3

 

Total

Cash equivalents

 

 

 

 

 

 

 

 

 

 

 

Money market funds

$

54,762 

 

$

 -

 

$

 -

 

$

54,762 

Commercial paper

 

 -

 

 

1,500 

 

 

 -

 

 

1,500 

 

$

54,762 

 

$

1,500 

 

$

 -

 

$

56,262 

 

 

 

 

 

 

 

 

 

 

 

 

Available-for-sale securities

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

$

 -

 

$

94,667 

 

$

 -

 

$

94,667 

U.S. Treasury securities

 

34,381 

 

 

 -

 

 

 -

 

 

34,381 

Agency discount notes

 

 -

 

 

1,027 

 

 

 -

 

 

1,027 

Commercial paper

 

 -

 

 

40,070 

 

 

 -

 

 

40,070 

 

$

34,381 

 

$

135,764 

 

$

 -

 

$

170,145 

 

 

The fair value of our financial assets at March 31, 2012, was determined using the following inputs (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quoted Prices

 

 

 

 

 

 

 

in Active

 

Significant

 

 

 

 

 

Markets for

 

Other

 

Significant

 

 

 

Identical

 

Observable

 

Unobservable

 

 

 

Assets

 

Inputs

 

Inputs

 

 

 

Level 1

 

Level 2

 

Level 3

 

Total

Cash equivalents

 

 

 

 

 

 

 

 

 

 

 

Money market funds

$

40,557 

 

$

 -

 

$

 -

 

$

40,557 

Commercial paper

 

 -

 

 

15,952 

 

 

 -

 

 

15,952 

Corporate debt securities

 

 -

 

 

1,112 

 

 

 -

 

 

1,112 

 

$

40,557 

 

$

17,064 

 

$

 -

 

$

57,621 

 

 

 

 

 

 

 

 

 

 

 

 

Available-for-sale securities

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

$

 -

 

$

48,025 

 

$

 -

 

$

48,025 

U.S. Treasury securities

 

30,261 

 

 

 -

 

 

 -

 

 

30,261 

Agency discount notes

 

 -

 

 

16,796 

 

 

 -

 

 

16,796 

Commercial paper

 

 -

 

 

23,709 

 

 

 -

 

 

23,709 

 

$

30,261 

 

$

88,530 

 

$

 -

 

$

118,791 

 

Accounts Receivable, Net
Accounts Receivable, Net

5.      Accounts Receivable, net 

            

            The following are the components of accounts receivable, net (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 30,

 

March 31,

 

2013

 

2012

Gross accounts receivable

$

69,590 

 

$

44,524 

Allowance for doubtful accounts

 

(301)

 

 

(371)

Accounts receivable, net

$

69,289 

 

$

44,153 

The following table summarizes the changes in the allowance for doubtful accounts (in thousands):

 

 

 

 

 

 

 

Balance, March 27, 2010

$

(488)

Bad debt expense, net of recoveries

 

67 

Balance, March 26, 2011

 

(421)

Bad debt expense, net of recoveries

 

50 

Balance, March 31, 2012

 

(371)

Bad debt expense, net of recoveries

 

70 

Balance, March 30, 2013

 

(301)

 

Goodwill And Intangibles, Net
Goodwill And Intangibles, Net

6.      Goodwill and Intangibles, net

 

            The goodwill balance included on the Consolidated Balance Sheets under the caption “Goodwill and intangibles, net” is $6.0 million at March 30, 2013 and March 31, 2012.

 

 

The following information details the gross carrying amount and accumulated amortization of our intangible assets (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 30, 2013

 

 

March 31, 2012

Intangible Category (Weighted-Average Amortization period (years))

 

Gross Amount

 

 

Accumulated Amortization

 

 

Gross Amount

 

 

Accumulated Amortization

Core technology (a)

$

1,390 

 

$

(1,390)

 

$

1,390 

 

$

(1,390)

License agreement (a)

 

440 

 

 

(440)

 

 

440 

 

 

(440)

Existing technology (10.1)

 

5,566 

 

 

(3,802)

 

 

17,235 

 

 

(7,318)

Trademarks (a)(b)

 

320 

 

 

(320)

 

 

2,758 

 

 

(320)

Non-compete agreements (b)

 

 -

 

 

 -

 

 

398 

 

 

(258)

Customer relationships (b)

 

 -

 

 

 -

 

 

4,682 

 

 

(1,515)

Technology licenses (3.2)

 

16,303 

 

 

(13,417)

 

 

14,187 

 

 

(11,608)

Total

$

24,019 

 

$

(19,369)

 

$

41,090 

 

$

(22,849)

 

(a)

Intangible assets are fully amortized.

(b)

Intangible assets existing at March 31, 2012 were fully or partially removed as part of the asset sale discussed in Note 7.  

 

Amortization expense for all intangibles in fiscal years 2013, 2012, and 2011 was $3.4 million, $3.7 million, and $3.3 million, respectively.  The following table details the estimated aggregate amortization expense for all intangibles owned as of March 30, 2013, for each of the five succeeding fiscal years (in thousands):

 

 

 

 

 

 

 

For the year ended March 29, 2014

$

2,602 

For the year ended March 28, 2015

$

1,809 

For the year ended March 26, 2016

$

218 

For the year ended March 25, 2017

$

21 

For the year ended March 31, 2018

$

 -

 

Asset Sale
Asset Sale

7.     Asset Sale

 

The Company entered into an agreement to sell certain assets associated with Apex Precision Power (“Apex”) products in Tucson, Arizona for $26.1 million.  On August 17, 2012, the Company closed the transaction under this agreement.  After closing the transaction, the Company maintained a high voltage / high power IC design team in Tucson.  See Note 9 for information regarding the subsequent closure and relocation of the Tucson design center. The Company received $22.2 million in cash and has recorded a long-term note receivable for $3.9 million to be paid in its entirety by August 17, 2014.  The gain recorded on the sale was $0.2 million and is included on the Consolidated Statement of Comprehensive Income under the caption, “Restructuring and other, net”.

 

Revolving Line Of Credit
Revolving Line Of Credit

8.     Revolving Line of Credit

 

            The Company maintained a revolving credit agreement (“Credit Agreement”) with Wells Fargo Bank, National Association, as administrative agent and issuing lender, Barclays Bank, as syndication agent, Wells Fargo Securities, LLC and Barclays Capital, as joint lead arrangers and co-book managers.  The aggregate borrowing limit under the unsecured revolving credit facility was $100 million with a $15 million letter of credit sublimit and was intended to provide the Company with short-term borrowings for working capital and other general corporate purposes.  The interest rate payable was, at the Company's election, (i) a base rate plus the applicable margin, where the base rate is determined by reference to the highest of 1) the prime rate publicly announced by the administrative agent, 2) the Federal Funds Rate plus 0.50%, and 3) LIBOR for a one month period plus the difference between the applicable margin for LIBOR rate loans and the applicable margin for base rate loans, or (ii) the LIBOR rate plus the applicable margin that varies according to the leverage ratio of the borrower.  Certain representations and warranties were required under the Credit Agreement, and the Company must have been in compliance with specified financial covenants, including (i) the requirement that the Company maintain a ratio of consolidated funded indebtedness to consolidated EBITDA of not greater than 1.75 to 1.0, computed in accordance with the terms of the Credit Agreement, and (ii) a minimum ratio of consolidated EBITDA to consolidated interest expense of not less than 3.50 to 1.0.  At March 30, 2013, the Company was in compliance with these covenants.

 

            At March 30, 2013, the Company had no outstanding amounts under the facility.  Additionally, there were no borrowings under the facility during fiscal year 2013.  The credit facility expired on April 19, 2013 and was not renewed.

 

Restructuring Costs
Restructuring Costs

9.      Restructuring Costs

 

            On November 6, 2012, the Company committed to a plan to close its Tucson, Arizona design center and move those operations, including development efforts related to motor control technology, to the Company’s headquarters in Austin, Texas.  This restructuring eliminated approximately 25 employees in Tucson, Arizona, or 4% of the Company’s total workforce, as well as relocated to Austin, Texas approximately 20 positions, which are primarily research and development positions.  As of December 29, 2012, the closure was materially completed.

 

            The Company incurred a one-time charge for relocation, severance-related items and facility-related costs to operating expenses totaling $3.5 million in the third quarter of fiscal year 2013.  This charge, along with asset sale activities described in Note 7, are presented as a separate line item on the consolidated statement of comprehensive income in operating expenses under the caption “Restructuring and other, net,” which was and will be paid through calendar year 2015.  The charge included $1.1 million in relocation and related costs and $2.4 million in facility related costs and other related charges.

 

            Of the $3.5 million expense incurred, approximately $2.0 million has been paid, and consisted of severance and relocation-related costs of approximately $0.9 million, an asset impairment charge of approximately $1.0 million, and facility-related costs of approximately $0.1 million.  As of March 30, 2013, we have a remaining restructuring accrual of $1.5 million, included in “Other accrued liabilities” on the consolidated balance sheet.

 

Employee Benefit Plans
Employee Benefit Plans

10.      Employee Benefit Plans

 

            We have a 401(k) Profit Sharing Plan (the “401(k) Plan”) covering all of our qualifying domestic employees.  Under the 401(k) Plan, employees may elect to contribute any percentage of their annual compensation up to the annual IRS limitations.  We match 50 percent of the first 6 percent of the employees’ annual contribution to the plan.  We made matching employee contributions of $1.5 million, $1.3 million, and $1.0 million during fiscal years 2013, 2012, and 2011, respectively.

 

Equity Compensation
Equity Compensation

11.      Equity Compensation

 

The Company is currently granting equity awards from the 2006 Stock Incentive Plan (the “Plan”), which was approved by stockholders in July 2006.  The Plan provides for granting of stock options, restricted stock awards, restricted stock units, performance awards, phantom stock awards, and bonus stock awards, or any combination of the foregoing.  To date, the Company has granted stock options, restricted stock awards, and restricted stock units under the Plan.  Stock options generally vest between zero and four years, and are exercisable for a period of ten years from the date of grant.  Generally, restricted stock awards are subject to vesting schedules up to four years.  Restricted stock units are generally subject to vesting from one to three years, depending upon the terms of the grant.

 

 

The following table summarizes the activity in total shares available for grant (in thousands):

 

 

 

 

 

 

 

 

 

Shares

 

 

Available for

 

 

Grant

Balance, March 27, 2010

 

9,930 

Plans terminated

 

(300)

Granted

 

(1,927)

Forfeited

 

472 

Balance, March 26, 2011

 

8,175 

Plans terminated

 

(34)

Granted

 

(2,049)

Forfeited

 

165 

Balance, March 31, 2012

 

6,257 

Plans terminated

 

 -

Granted

 

(1,600)

Forfeited

 

468 

Balance, March 30, 2013

 

5,125 

 

Stock Compensation Expense

 

The following table summarizes the effects of stock-based compensation on cost of goods sold, research and development, sales, general and administrative, pre-tax income, and net income after taxes for options granted under the Company’s equity incentive plans (in thousands, except per share amounts):  

 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal Years Ended

 

 

March 30, 2013

 

 

March 31, 2012

 

 

March 26, 2011

Cost of sales

$

751 

 

$

398 

 

$

243 

Research and development

 

10,549 

 

 

5,590 

 

 

2,641 

Sales, general and administrative

 

10,195 

 

 

6,190 

 

 

5,257 

Effect on pre-tax income

 

21,495 

 

 

12,178 

 

 

8,141 

Income Tax Benefit

 

(106)

 

 

 -

 

 

 -

Total share-based compensation expense (net of taxes)

 

21,389 

 

 

12,178 

 

 

8,141 

Share-based compensation effects on basic earnings per share

$

0.33 

 

$

0.19 

 

$

0.12 

Share-based compensation effects on diluted earnings per share

 

0.32 

 

 

0.18 

 

 

0.11 

Share-based compensation effects on operating activities cash flow

 

21,389 

 

 

12,178 

 

 

8,141 

Share-based compensation effects on financing activities cash flow

 

106 

 

 

 -

 

 

 -

            The total share based compensation expense included in the table above and which is attributable to restricted stock awards and restricted stock units was $16.3 million, $6.3 million, and $1.1 million for fiscal years 2013, 2012, and 2011, respectively.

 

            As of March 30, 2013, there was $39.7 million of compensation costs related to non-vested stock options, restricted stock awards, and restricted stock units granted under the Company’s equity incentive plans not yet recognized in the Company’s financial statements.  The unrecognized compensation cost is expected to be recognized over a weighted average period of 0.96 years for stock options, 1.27 years for restricted stock awards, and 1.57 years for restricted stock units.

 

Stock Option Awards

 

We estimated the fair value of each stock option grant on the date of grant using the Black-Scholes option-pricing model using a dividend yield of zero and the following additional assumptions:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended

 

 

March 30, 2013

(a)

 

March 31, 2012

 

 

March 26, 2011

 

Expected stock price volatility

 

63.42

%

 

59.25 - 66.11

%

 

52.03 - 67.11

%

Risk-free interest rate

 

0.31

%

 

0.27 - 1.43

%

 

1.19 - 2.06

%

Expected term (in years)

 

2.46

 

 

2.32 - 3.82

 

 

3.83 - 4.34

 

   

(a)

 Actual assumptions at time of share issuance used.

 

The Black-Scholes valuation calculation requires us to estimate key assumptions such as stock price volatility, expected term, risk-free interest rate and dividend yield.  The expected stock price volatility is based upon implied volatility from traded options on our stock in the marketplace.  The expected term of options granted is derived from an analysis of historical exercises and remaining contractual life of stock options, and represents the period of time that options granted are expected to be outstanding.  The risk-free interest rate reflects the yield on zero-coupon U.S. Treasury securities for a period that is commensurate with the expected term assumption.  Finally, we have never paid cash dividends, do not currently intend to pay cash dividends, and thus have assumed a zero percent dividend yield.

 

Using the Black-Scholes option valuation model, the weighted average estimated fair values of employee stock options granted in fiscal years 2013, 2012, and 2011, were $20.43, $7.58, and $9.61, respectively. 

 

During fiscal year 2013, 2012, and 2011, we received a net $12.0 million, $4.1 million, and $31.0 million, respectively, from the exercise of 1.7 million, 0.6 million and 4.7 million, respectively, stock options granted under the Company’s stock Plan.

 

The total intrinsic value of stock options exercised during fiscal year 2013, 2012, and 2011, was $48.6 million, $7.6 million, and $50.4 million, respectively.  Intrinsic value represents the difference between the market value of the Company’s common stock at the time of exercise and the strike price of the stock option.

 

As of March 30, 2013, approximately 9.4 million shares of common stock were reserved for issuance under the stock option Plan.  

 

 

Additional information with respect to stock option activity is as follows (in thousands, except per share amounts): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding Options

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

Number

 

 

Exercise Price

Balance, March 27, 2010

 

10,379 

 

$

6.74 

Options granted

 

977 

 

 

16.75 

Options exercised

 

(4,718)

 

 

6.57 

Options forfeited

 

(153)

 

 

5.90 

Options expired

 

(304)

 

 

23.68 

Balance, March 26, 2011

 

6,181 

 

$

7.63 

Options granted

 

450 

 

 

15.63 

Options exercised

 

(593)

 

 

6.88 

Options forfeited

 

(67)

 

 

7.70 

Options expired

 

(67)

 

 

15.68 

Balance, March 31, 2012

 

5,904 

 

$

8.23 

Options granted

 

264 

 

 

37.22 

Options exercised

 

(1,746)

 

 

6.88 

Options forfeited

 

(144)

 

 

12.52 

Options expired

 

 -

 

 

20.25 

Balance, March 30, 2013

 

4,278 

 

$

10.42 

 

Additional information with regards to outstanding options that are vesting, expected to vest, or exercisable as of March 30, 2013 is as follows (in thousands, except years and per share amounts): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

Weighted Average

 

 

 

 

 

Number of

 

 

Average

 

Remaining Contractual

 

 

Aggregate

 

 

Options

 

 

Exercise price

 

Term (years)

 

 

Intrinsic Value

Vested and expected to vest

 

4,196 

 

$

10.15 

 

6.07 

 

$

56,376 

Exercisable

 

3,217 

 

$

7.76 

 

5.51 

 

$

48,228 

 

In accordance with U.S. GAAP, stock options outstanding that are expected to vest are presented net of estimated future option forfeitures, which are estimated as compensation costs are recognized.  Options with a fair value of $4.8 million, $6.3 million, and $6.0 million, became vested during fiscal years 2013, 2012, and 2011, respectively.

 

The following table summarizes information regarding outstanding and exercisable options as of March 30, 2013 (in thousands, except per share amounts): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding

 

Options Exercisable

 

 

 

 

Weighted Average

 

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

Weighted

 

 

 

Weighted

 

 

 

 

Contractual Life

 

Average Exercise

 

Number

 

Average

Range of Exercise Prices

 

Number

 

(years)

 

Price

 

Exercisable

 

Exercise Price

$2.59 - $5.25

 

764 

 

4.78 

 

$

5.05 

 

754 

 

$

5.05 

$5.49 - $5.53

 

58 

 

6.39 

 

 

5.50 

 

44 

 

 

5.50 

$5.55 - $5.55

 

1,217 

 

6.48 

 

 

5.55 

 

961 

 

 

5.55 

$5.66 - $7.87

 

891 

 

4.10 

 

 

7.05 

 

873 

 

 

7.05 

$8.06 - $16.25

 

874 

 

7.72 

 

 

15.18 

 

434 

 

 

14.90 

$16.28 - $38.99

 

474 

 

8.11 

 

 

29.79 

 

151 

 

 

19.60 

 

 

4,278 

 

6.11 

 

$

10.42 

 

3,217 

 

$

7.76 

               As of March 30, 2013 and March 31, 2012, the number of options exercisable was 3.2 million and 3.8 million, respectively.

 

Restricted Stock Awards

 

The Company periodically grants restricted stock awards (“RSA’s”) to select employees.  The grant date for these awards is equal to the measurement date and the awards are valued as of the measurement date and amortized over the requisite vesting period, which is no more than four years.  Each full value award, including RSA’s, reduces the total shares available for grant under the Plan at a rate of 1.5 shares per RSA granted.  As of March 30, 2013, approximately 0.1 million shares attributable to RSA awards were reserved for issuance under the Plan.  A summary of the activity for RSA’s in fiscal year 2013, 2012, and 2011 is presented below (in thousands, except per share amounts):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

 

 

 

Grant Date

Aggregate

 

Number of

 

 

Fair Value

Intrinsic 

 

Shares

 

 

(per share)

value (1)

March 27, 2010

49 

 

$

6.20 

 

Granted

 

 

17.28 

 

Vested

(7)

 

 

7.35 
134 

Forfeited

(2)

 

 

7.35 

 

March 26, 2011

45 

 

 

7.21 

 

Granted

49 

 

 

15.31 

 

Vested

(54)

 

 

14.57 
826 

Forfeited

    -

 

 

    -

 

March 31, 2012

40 

 

 

7.19 

 

Granted

27 

 

 

28.24 

 

Vested

(62)

 

 

15.45 
1,657 

Forfeited

 -

 

 

 -

 

March 30, 2013

 

$

17.28 

 

 

(1)

Represents the value of Cirrus stock on the date that the restricted stock vested.

            The weighted average remaining recognition period for RSA’s outstanding as of March 30, 2013 was 1.27 years.  RSA’s with a fair value of $951 thousand, $637 thousand, and $37 thousand became vested during fiscal years 2013, 2012, and 2011, respectively.

 

Restricted Stock Units

 

            Commencing in fiscal year 2011, the Company began granting restricted stock units (“RSU’s”) to select employees. These awards are valued as of the grant date and amortized over the requisite vesting period.  Generally, RSU’s vest 100 percent on the first to third anniversary of the grant date depending on the vesting specifications.  Each full value award, including RSU’s, reduces the total shares available for grant under the 2006 option plan at a rate of 1.5 shares per RSU granted.  As of March 30, 2013, approximately 3.2 million shares attributable to RSU awards were reserved for issuance under the Plan, which includes the additional shares associated with this full value award multiplier. A summary of the activity for RSU’s in fiscal year 2013, 2012, and 2011 is presented below (in thousands, except year and per share amounts):

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average

 

 

 

 

Weighted

Remaining

 

 

 

 

Average

Contractual Term

 

Shares

 

 

Fair Value

(years)

March 27, 2010

 -

 

$

 -

 

Granted

628 

 

 

16.41 

 

Vested

 -

 

 

 -

 

Forfeited

(8)

 

 

16.25 

 

March 26, 2011

620 

 

 

16.41 

2.54

Granted

1,017 

 

 

16.59 

 

Vested

 -

 

 

 -

 

Forfeited

(21)

 

 

16.04 

 

March 31, 2012

1,616 

 

 

16.52 

1.94

Granted

864 

 

 

37.26 

 

Vested

(193)

 

 

20.56 

 

Forfeited

(216)

 

 

21.46 

 

March 30, 2013

2,071 

 

$

23.66 

1.57

 

       Additional information with regards to outstanding restricted stock units that are vesting or expected to vest as of March 30, 2013, is as follows (in thousands, except year and per share amounts): 

   

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

Weighted Average

 

 

 

 

 

Average

 

Remaining Contractual

 

 

Shares

 

 

Fair Value

 

Term (years)

Vested and expected to vest

 

1,888

 

$

23.66

 

1.53

 

            RSU’s outstanding that are expected to vest are presented net of estimated future forfeitures, which are estimated as compensation costs are recognized.  RSU’s with a fair value of $3.8 million became vested during fiscal year 2013.  No RSU’s became vested during fiscal year 2012 or 2011.  In fiscal year 2013, the Company required employees with vested RSU’s the option to cash settle or net settle, removing the option to sell all.  As a result, the Company repurchases a portion of the shares at fair value, and uses the cash on behalf of the employee to satisfy the tax withholding requirements.  In fiscal year 2013, the vesting of RSU’s reduced the authorized and unissued share balance by approximately 0.2 million, while the net released, outstanding share balance increased by approximately 0.1 million shares and resulted in the $1.7 million payment and subsequent retirement of these shares out of the Plan. 

Commitments And Contingencies
Commitments And Contingencies

12.      Commitments and Contingencies

 

Facilities and Equipment Under Operating Lease Agreements

 

            With the exception of our corporate headquarters and select surrounding properties, we lease our facilities and certain equipment under operating lease agreements, some of which have renewal options.  Certain of these arrangements provide for lease payment increases based upon future fair market rates.  As of May 1, 2013, our principal facilities are located in Austin, Texas. 

 

            The Company closed operations in Tucson, Arizona during fiscal year 2013, which included 28,000 square feet of leased office space which was primarily occupied by engineering personnel.  The term of this lease extends through May 2015.

 

The aggregate minimum future rental commitments under all operating leases, net of sublease income, for the following fiscal years are (in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Facilities

 

 

Subleases

 

 

Net Facilities Commitments

 

 

Equipment Commitments

 

 

Total Commitments

2014

$

2,974 

 

$

112 

 

$

2,862 

 

$

11 

 

$

2,873 

2015

 

2,919 

 

 

76 

 

 

2,843 

 

 

 

 

2,848 

2016

 

2,271 

 

 

 -

 

 

2,271 

 

 

 

 

2,273 

2017

 

2,208 

 

 

 -

 

 

2,208 

 

 

 

 

2,208 

2018

 

543 

 

 

 -

 

 

543 

 

 

 -

 

 

543 

Thereafter

 

69 

 

 

 -

 

 

69 

 

 

 -

 

 

69 

Total minimum lease payment

$

10,984 

 

$

188 

 

$

10,796 

 

$

18 

 

$

10,814 

 

               Total rent expense was approximately $3.2 million, $4.7 million, and $4.6 million, for fiscal years 2013, 2012, and 2011, respectively.  Sublease rental income was $0.1 million, $0.4 million, $1.1 million, for fiscal years 2013, 2012, and 2011, respectively. 

 

Wafer, Assembly and Test Purchase Commitments 

 

            We rely primarily on third-party foundries for our wafer manufacturing needs.  As of March 30, 2013, we had agreements with multiple foundries for the manufacture of wafers.  On December 22, 2011, the Company entered into a $10 million Capacity Investment and Loading Agreement with STATS ChipPAC Ltd (Supplier Agreement) in order to secure assembly and test capacity for certain products.  An initial $5 million payment was made on January 24, 2012, with the remaining $5 million paid July 2, 2012, after certain capacity expansion commitments had been achieved by STATS ChipPAC.  This liability was recorded on the consolidated balance sheet as of March 31, 2012, under the caption “Supplier Agreement”.  As part of the agreement, we are eligible to receive rebates on our purchases up to the full amount of the specified $10 million in the Supplier Agreement upon our meeting certain purchase volume milestones.  Based on our current projections, we expect to receive the full amount of our $10 million payments back in rebates during the term of the agreement.  We have utilized $4.3 million during fiscal year 2013 related to the agreement.  Other than the previously mentioned agreement, our foundry agreements do not have volume purchase commitments or "take or pay" clauses and provide for purchase commitments based on purchase orders.  Cancellation fees or other charges may apply and are generally dependent upon whether wafers have been started or the stage of the manufacturing process at which the notice of cancellation is given.  As of March 30, 2013, we had foundry commitments of $31.0 million. 

 

            In addition to our wafer supply arrangements, we contract with third-party assembly vendors to package the wafer die into finished products.  Assembly vendors provide fixed-cost-per-unit pricing, as is common in the semiconductor industry.  We had non-cancelable assembly purchase orders with numerous vendors totaling $2.3 million at March 30, 2013.

 

            Test vendors provide fixed-cost-per-unit pricing, as is common in the semiconductor industry.  Our total non-cancelable commitment for outside test services as of March 30, 2013 was $1.1 million.

 

            Other open purchase orders as of March 30, 2013 are insignificant in nature.

Legal Matters
Legal Matters

13.      Legal Matters

 

            From time to time, we are involved in legal proceedings concerning matters arising in connection with the conduct of our business activities.  We regularly evaluate the status of legal proceedings in which we are involved, to assess whether a loss is probable or there is a reasonable possibility that a loss or additional loss may have been incurred and determine if accruals are appropriate.  We further evaluate each legal proceeding to assess whether an estimate of possible loss or range of loss can be made, if accruals are not appropriate.   We intend to vigorously defend ourselves against the allegations made in the legal cases described below. 

 

            For the cases described below, management is unable to provide a meaningful estimate of the possible loss or range of possible loss because, among other reasons, (i) the proceedings are in various stages; (ii) damages have not been sought or specified; (iii) damages are unsupported and/or exaggerated; (iv) there is uncertainty as to the outcome of pending appeals or motions; (v) there are significant factual issues to be resolved; and/or (vi) there are novel legal issues or unsettled legal theories to be presented or a large number of parties.  For these cases, however, management does not believe, based on currently available information, that the outcomes of these proceedings will have a material adverse effect on our financial condition.  However, the ultimate resolutions of these various proceedings and matters are inherently difficult to predict; as such, our operating results could be materially affected by the unfavorable resolution of one or more of these proceedings or matters for any particular period, depending, in part, upon the operating results for such period.

 

            On June 4, 2012, U.S. Ethernet Innovations, LLC (the “Plaintiff”) filed suit against Cirrus Logic and two other defendants in the U.S. District Court, Eastern District of Texas. The Plaintiff alleges that Cirrus Logic infringed four U.S. patents relating to Ethernet technology.  In its complaint, the Plaintiff indicated that it is seeking unspecified monetary damages, including up to treble damages for willful infringement. We answered the complaint on June 29, 2012, denying the allegations of infringement and seeking a declaratory judgment that the patents in suit were invalid and not infringed.  On September 21, 2012, the Plaintiff amended its complaint to allege that we infringed on a fifth patent related to similar technology.  We answered the amended complaint on October 8, 2012, again denying the allegations of infringement and seeking a declaratory judgment that the patents in suit were invalid and not infringed.

 

            On February 4, 2013, a purported shareholder filed a class action complaint in the United States District Court for the Southern District of New York against the Company and two of the Company’s executives (the “Securities Case”).  Koplyay v. Cirrus Logic, Inc., et al. Civil Action No. 13-CV-0790.  The complaint alleges that the defendants violated the federal securities laws by making materially false and misleading statements regarding our business results between July 31, 2012, and October 31, 2012, and seeks unspecified damages along with plaintiff’s costs and expenses, including attorneys’ fees.  A second complaint was filed on April 13, 2013, by a different purported shareholder, in the same court, setting forth substantially the same allegations.  On April 19, 2013, the court appointed the plaintiff and counsel in the first class action complaint as the lead plaintiff and lead counsel.  The lead plaintiff filed an amended complaint on May 1, 2013, including substantially the same allegations as the original complaint. 

 

            On April 13, 2013, another purported shareholder filed a shareholder derivative complaint against several of our current officers and directors in the District Court of Travis County, Texas, 53rd Judicial District (the “Derivative Case”).  Graham, derivatively on behalf of Cirrus Logic, Inc. v. Rhode, et. al., Cause No. D-1-GN-13-001285.  In this complaint, the plaintiff makes allegations similar to those presented in the Securities Case, but the plaintiff asserts various state law causes of action, including claims of breach of fiduciary duty and unjust enrichment.  The Company is named solely as a nominal defendant against whom no recovery is sought.  

 

Patent Agreement, Net
Patent Agreement, Net

14.     Patent Agreement, Net

 

            On July 13, 2010, we entered into a patent purchase agreement for the sale of certain Company owned patents.  As a result of this agreement, on August 31, 2010, the Company received cash consideration of $4.0 million from the purchaser.  The proceeds were recorded during fiscal year 2011 as a recovery of costs previously incurred and are reflected as a separate line item on the Consolidated Statements of Comprehensive Income in operating expenses under the caption “Patent agreement, net.” 

 

Stockholder's Equity
Stockholder's Equity

15.      Stockholders’ Equity

 

Share Repurchase Program

 

            On November 4, 2010, we announced that our Board of Directors authorized an $80 million share repurchase program.  As of March 31, 2012, the Company had repurchased 5.1 million shares at a cost of $79.5 million, or an average cost of $15.51 per share.  During the third quarter of the current fiscal year, the Company completed this stock repurchase program and repurchased the remaining outstanding shares in conjunction with the new share repurchase program, announced below.  There are no outstanding remaining available repurchase obligations under this plan.  All repurchased common stock shares were retired.

 

            On November 20, 2012, we announced that our Board of Directors authorized a share repurchase program of up to $200 million of the Company’s common stock.  The Company repurchased 3.0 million shares of its common stock for $86.1 million (including the remaining $0.5 million available under the 2010 plan discussed above) during fiscal year 2013, at an average cost of $28.59 per share, leaving approximately $114.4 million available for repurchase under this plan as of March 30, 2013.  All of these shares were repurchased in the open market and were funded from existing cash.  All shares of our common stock that were repurchased were retired as of March 30, 2013.

 

Preferred Stock

 

            We have 5.0 million shares of Preferred Stock authorized.  As of March 30, 2013 we have not issued any of the authorized shares. 

Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss

16.      Accumulated Other Comprehensive Loss

 

Our accumulated other comprehensive loss is comprised of foreign currency translation adjustments and unrealized gains and losses on investments classified as available-for-sale.  The foreign currency translation adjustments are not currently adjusted for income taxes because they relate to indefinite investments in non-U.S. subsidiaries that have since changed from a foreign functional currency to a U.S dollar functional currency. 

 

The following table summarizes the changes in the components of accumulated other comprehensive loss, net of tax (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized Gains

 

 

 

 

 

Foreign

 

 

(Losses) on

 

 

 

 

 

Currency

 

 

Securities

 

 

Total

Balance, March 26, 2011

$

(770)

 

$

16 

 

$

(754)

Current period activity

 

 -

 

 

(8)

 

 

(8)

Balance, March 31, 2012

 

(770)

 

 

 

 

(762)

Current period activity

 

 -

 

 

(157)

 

 

(157)

Balance, March 30, 2013

$

(770)

 

$

(149)

 

$

(919)

 

Income Taxes
Income Taxes

17.      Income Taxes

 

Income before income taxes consisted of (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended

 

March 30,

 

March 31,

 

March 26,

 

2013

 

2012

 

2011

United States

$

200,124 

 

$

79,425 

 

$

83,569 

Non-U.S.

 

1,066 

 

 

558 

 

 

645 

 

$

201,190 

 

$

79,983 

 

$

84,214 

 

The provision (benefit) for income taxes consists of (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended

 

March 30,

 

March 31,

 

March 26,

 

2013

 

2012

 

2011

Current:

 

 

 

 

 

 

 

 

Federal

$

3,537 

 

$

1,322 

 

$

163 

State

 

323 

 

 

518 

 

 

312 

Non-U.S.

 

243 

 

 

261 

 

 

204 

Total current tax provision

$

4,103 

 

$

2,101 

 

$

679 

 

 

 

 

 

 

 

 

 

Deferred:

 

 

 

 

 

 

 

 

U.S.

 

60,506 

 

 

(10,102)

 

 

(120,057)

Non-U.S.

 

(17)

 

 

 

 

89 

Total deferred tax provision (benefit)

 

60,489 

 

 

(10,101)

 

 

(119,968)

Total tax provision (benefit)

$

64,592 

 

$

(8,000)

 

$

(119,289)

 

The effective income tax rates differ from the rates computed by applying the statutory federal rate to pretax income as follows (in percentages):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended

 

March 30,

 

March 31,

 

March 26,

 

2013

 

2012

 

2011

Expected income tax provision at the U.S. federal statutory rate

 

35.0 

 

 

35.0 

 

 

35.0 

Valuation allowance changes affecting the provision of income taxes

 

(1.3)

 

 

(46.7)

 

 

(178.6)

Foreign taxes at different rates

 

(0.1)

 

 

 -

 

 

0.1 

R&D credit

 

(2.1)

 

 

 -

 

 

 -

Stock compensation

 

0.1 

 

 

1.0 

 

 

(0.1)

Nondeductible expenses

 

0.3 

 

 

0.1 

 

 

1.1 

Other

 

0.2 

 

 

0.6 

 

 

0.9 

Provision (benefit) for income taxes

 

32.1 

 

 

(10.0)

 

 

(141.6)

 

 

Significant components of our deferred tax assets and liabilities as of March 30, 2013 and March 31, 20121 are (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 30,

 

March 31,

 

2013

 

2012

Deferred tax assets:

 

 

 

 

 

Inventory valuation

$

12,065 

 

$

3,240 

Accrued expenses and allowances

 

5,077 

 

 

3,656 

Net operating loss carryforwards

 

28,162 

 

 

105,220 

Research and development tax credit carryforwards

 

37,054 

 

 

36,032 

State tax credit carryforwards

 

237 

 

 

244 

Capitalized research and development

 

6,601 

 

 

9,779 

Other

 

21,505 

 

 

18,747 

Total deferred tax assets

$

110,701 

 

$

176,918 

Valuation allowance for deferred tax assets

 

(23,232)

 

 

(29,075)

Net deferred tax assets

$

87,469 

 

$

147,843 

 

 

 

 

 

 

Deferred tax liabilities:

 

 

 

 

 

Depreciation and amortization

$

5,238 

 

$

287 

Acquisition intangibles

 

623 

 

 

5,348 

Total deferred tax liabilities

$

5,861 

 

$

5,635 

Total net deferred tax assets

$

81,608 

 

$

142,208 

 

            These net deferred tax assets have been categorized on the Consolidated Balance Sheets as of March 30, 2013 and March 31, 2012 as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 30,

 

March 31,

 

2013

 

2012

Current deferred tax assets

$

64,937 

 

$

53,137 

Long-term deferred tax assets

 

16,671 

 

 

89,071 

Total net deferred tax assets

$

81,608 

 

$

142,208 

 

            The current and long-term deferred tax assets are disclosed separately under their respective captions on the consolidated balance sheets.

 

            The valuation allowance decreased by $5.8 million in fiscal year 2013 and $39.3 million in fiscal year 2012.  During fiscal year 2013, the valuation allowance that the Company had maintained on its capital loss carryforward was released due to the capital gain income generated by the sale of assets associated with the Company’s Apex products.  The Company maintained its valuation allowance on various state net operating losses and credits due to the likelihood that they will expire or go unutilized because the Company no longer has a significant apportionment in the jurisdiction in which the attribute was created.  The decrease in the fiscal year 2012 allowance was the result of a release of the valuation allowance on Federal net operating losses, research credits and other Federal deductions due to an expectation that forecasted income as of the end of fiscal year 2012 would be sufficient to utilize these deferred tax assets.  With regard to the remaining deferred tax assets, Management believes that the Company’s results from future operations will generate sufficient taxable income such that it is more likely than not that these deferred tax assets will be realized. 

 

            At March 30, 2013, we had federal net operating loss carryforwards of $177.1 million.  Of that amount, $20.9 million related to companies we acquired during fiscal year 2002 and are, therefore, subject to certain limitations under Section 382 of the Internal Revenue Code.  Because the Company has elected the “with and without” method for purposes of tracking its excess stock deductions, the amount of federal net operating loss included in deferred tax assets is $56.8 million, which yields a tax effected deferred tax asset of $19.9 million.  The Company had $120.3 million of excess stock deductions which are not included in deferred tax assets.  The tax benefit from these deductions will increase additional paid-in capital when they are deemed realized under the “with and without” method.  We had net operating losses in various states that total $101.6 million. The federal net operating loss carryforwards expire in fiscal years 2019 through 2033.  The state net operating loss carryforwards expire in fiscal years 2014 through 2029.  We also have non-U.S. net operating losses of $2.0 million, which do not expire. 

 

            There are federal research and development credit carryforwards of $22.5 million that expire in fiscal years 2014 through 2033.  There are $14.5 million of state research and development credits.  Of that amount, $2.8 million will expire in fiscal years 2022 through 2027.  The remaining $11.7 million of state research and development credits are not subject to expiration.  The American Taxpayer Relief Act of 2012 (the “Act”) was enacted on January 2, 2013.  The Act retroactively reinstates the federal research and development credit from January 1, 2012 through December 31, 2013.  As a result of the retroactive extension of the R&D credit, we recognized a $4.2 million benefit to tax expense during fiscal year 2013, a portion of which related to qualified research expenditures that were incurred during the last quarter of fiscal year 2012.

            We have approximately $228 thousand of cumulative undistributed earnings in certain non-U.S. subsidiaries.  We have not recognized a deferred tax liability on these undistributed earnings because the Company currently intends to reinvest these earnings in operations outside the U.S.  The unrecognized deferred tax liability on these earnings is approximately $81 thousand. 

 

            We record unrecognized tax benefits for the estimated risk associated with tax positions taken on tax returns.  A reconciliation of the beginning and ending amounts of unrecognized tax benefits is as follows (in thousands):

 

 

 

 

Balance at March 31, 2012

$

 -

Additions based on tax positions related to the current year

 

 -

Reductions for tax positions of prior years

 

 -

Settlements

 

 -

Reductions related to expirations of statutes of limitation

 

 -

Balance at March 30, 2013

$

 -

 

The Company does not believe that its unrecognized tax benefits will significantly increase or decrease during the next 12 months.

 

                   We accrue interest and penalties related to unrecognized tax benefits as a component of the provision for income taxes.  We did not record any interest or penalties during fiscal year 2013 or 2012.

 

                 The Company and its subsidiaries are subject to U.S. federal income tax as well as income tax in multiple state and foreign jurisdictions. Fiscal years 2010 through 2013 remain open to examination by the major taxing jurisdictions to which we are subject. 

Segment Information
Segment Information

18.      Segment Information

 

      We determine our operating segments in accordance with FASB guidelines.  Our Chief Executive Officer (“CEO”) has been identified as the chief operating decision maker under these guidelines. 

 

The Company operates and tracks its results in one reportable segment, but reports revenue performance in two product lines, which currently are audio and energy.  Our CEO receives and uses enterprise-wide financial information to assess financial performance and allocate resources, rather than detailed information at a product line level.  Additionally, our product lines have similar characteristics and customers.  They share operations support functions such as sales, public relations, supply chain management, various research and development and engineering support, in addition to the general and administrative functions of human resources, legal, finance and information technology.  Therefore, there is no complete, discrete financial information maintained for these product lines.  Revenue from our product lines are as follows (in thousands): 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal Years Ended

 

March 30,

 

March 31,

 

March 26,

 

 

2013

 

2012

 

2011

 

Audio Products

$

754,769 

 

$

350,743 

 

$

264,840 

 

Energy Products

 

55,017 

 

 

76,100 

 

 

104,731 

 

 

$

809,786 

 

$

426,843 

 

$

369,571 

 

 

Geographic Area

 

            The following illustrates sales by geographic locations based on the sales office location (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal Years Ended

 

March 30,

 

March 31,

 

March 26,

 

2013

 

2012

 

2011

United States

$

38,670 

 

$

50,230 

 

$

66,701 

United Kingdom

 

19,211 

 

 

23,927 

 

 

27,398 

China

 

700,051 

 

 

294,143 

 

 

205,775 

Hong Kong

 

8,590 

 

 

8,671 

 

 

9,216 

Japan

 

9,299 

 

 

15,196 

 

 

16,902 

South Korea

 

8,975 

 

 

9,781 

 

 

12,413 

Taiwan

 

11,694 

 

 

10,662 

 

 

13,073 

Other Asia

 

10,387 

 

 

13,063 

 

 

16,012 

Other non-U.S. countries

 

2,909 

 

 

1,170 

 

 

2,081 

Total consolidated sales

$

809,786 

 

$

426,843 

 

$

369,571 

 

The following illustrates property, plant and equipment, net, by geographic locations, based on physical location (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal Years Ended

 

March 30,

 

March 31,

 

2013

 

2012

United States

$

100,343 

 

$

66,530 

United Kingdom

 

23 

 

 

20 

China

 

137 

 

 

158 

Hong Kong

 

 

 

Japan

 

25 

 

 

167 

South Korea

 

 

 

Taiwan

 

70 

 

 

83 

Other Asia

 

14 

 

 

11 

Total consolidated property, plant and equipment, net

$

100,623 

 

$

66,978 

 

Quarterly Results (Unaudited)
Quarterly Results (Unaudited)

19.      Quarterly Results (Unaudited)

 

            The following quarterly results have been derived from our audited annual consolidated financial statements.  In the opinion of management, this unaudited quarterly information has been prepared on the same basis as the annual consolidated financial statements and includes all adjustments, including normal recurring adjustments, necessary for a fair presentation of this quarterly information.  This information should be read along with the financial statements and related notes.  The operating results for any quarter are not necessarily indicative of results to be expected for any future period. 

 

The unaudited quarterly statement of operations data for each quarter of fiscal years 2013 and 2012 were as follows (in thousands, except per share data):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal Year 2013

 

1st

 

2nd

 

3rd

 

4th

 

Quarter

 

Quarter

 

Quarter

 

Quarter

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

$

99,006 

 

$

193,774 

 

$

310,133 

 

$

206,873 

Gross margin

 

53,440 

 

 

100,087 

 

 

158,050 

 

 

83,614 

Net income

 

6,927 

 

 

35,449 

 

 

67,862 

 

 

26,360 

Basic income per share

$

0.11 

 

$

0.55 

 

$

1.04 

 

$

0.41 

Diluted income per share

 

0.10 

 

 

0.51 

 

 

0.99 

 

 

0.39 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal Year 2012

 

1st

 

2nd

 

3rd

 

4th

 

Quarter

 

Quarter

 

Quarter

 

Quarter

 

 

 

 

 

 

 

 

 

 

 

(1)

Net sales

$

92,242 

 

$

101,602 

 

$

122,368 

 

$

110,631 

Gross margin

 

47,709 

 

 

54,355 

 

 

66,030 

 

 

62,347 

Net income

 

9,178 

 

 

11,247 

 

 

16,731 

 

 

50,827 

Basic income per share

$

0.14 

 

$

0.17 

 

$

0.26 

 

$

0.79 

Diluted income per share

 

0.13 

 

 

0.17 

 

 

0.25 

 

 

0.75 

 

(1)

The $39.5 million tax benefit recorded in the fourth quarter of 2012 favorably impacted net income, as a result of a $37.3 million release in valuation allowance on deferred tax assets.

Description Of Business (Policy)

Basis of Presentation

 

            We prepare financial statements on a 52- or 53-week year that ends on the last Saturday in March.  Fiscal years 2011 and 2013 were 52-week years, whereas fiscal year 2012 was a 53-week year.

Principles of Consolidation

 

            The accompanying consolidated financial statements have been prepared in accordance with U. S. generally accepted accounting principles (U.S. GAAP) and include the accounts of the Company and its wholly-owned subsidiaries.  All significant intercompany balances and transactions have been eliminated.

Reclassifications    

 

            Certain reclassifications have been made to prior year balances in order to conform to the current year’s presentation of financial information.

Use of Estimates

 

            The preparation of financial statements in accordance with U.S. GAAP requires the use of management estimates.  These estimates are subjective in nature and involve judgments that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at fiscal year-end and the reported amounts of revenue and expenses during the reporting period.  Actual results could differ from these estimates.

Summary Of Significant Accounting Policies (Policy)

Cash and Cash Equivalents

 

            Cash and cash equivalents consist primarily of money market funds, commercial paper, and U.S. Government Treasury and Agency instruments with original maturities of three months or less at the date of purchase

Marketable Securities

 

            We determine the appropriate classification of marketable securities at the time of purchase and reevaluate this designation as of each balance sheet date.  We classify these securities as either held-to-maturity, trading, or available-for-sale.  As of March 30, 2013 and March 31, 2012, all marketable securities and restricted investments were classified as available-for-sale securities.  The Company classifies its investments as “available for sale” because it expects to possibly sell some securities prior to maturity.  The Company’s investments are subject to market risk, primarily interest rate and credit risk.  The Company’s investments are managed by an outside professional manager within investment guidelines set by the Company.  Such guidelines include security type, credit quality, and maturity, and are intended to limit market risk by restricting the Company’s investments to high quality debt instruments with relatively short-term maturities.  The fair value of investments is determined using observable or quoted market prices for those securities.

 

            Available-for-sale securities are carried at fair value, with unrealized gains and losses included as a component of accumulated other comprehensive loss.  Realized gains and losses, declines in value judged to be other than temporary, and interest on available-for-sale securities are included in net income.  The cost of securities sold is based on the specific identification method.

Inventories 

 

            We use the lower of cost or market method to value our inventories, with cost being determined on a first-in, first-out basis.  One of the factors we consistently evaluate in the application of this method is the extent to which products are accepted into the marketplace.  By policy, we evaluate market acceptance based on known business factors and conditions by comparing forecasted customer unit demand for our products over a specific future period, or demand horizon, to quantities on hand at the end of each accounting period.

 

            On a quarterly and annual basis, we analyze inventories on a part-by-part basis.  Inventory quantities on hand in excess of forecasted demand are considered to have reduced market value and, therefore, the cost basis is adjusted to the lower of cost or market.  Typically, market values for excess or obsolete inventories are considered to be zero.  Product life cycles and the competitive nature of the industry are factors considered in the estimation of customer unit demand at the end of each quarterly accounting period.

 

            Inventories were comprised of the following (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 30,

 

March 31,

 

2013

 

2012

Work in process

$

34,169 

 

$

30,921 

Finished goods

 

85,131 

 

 

24,994 

 

$

119,300 

 

$

55,915 

 

Property, Plant and Equipment, net

 

            Property, plant and equipment is recorded at cost, net of depreciation and amortization.  Depreciation and amortization is calculated on a straight-line basis over estimated economic lives, ranging from three to 39 years.  Leasehold improvements are depreciated over the shorter of the term of the lease or the estimated useful life.  Furniture, fixtures, machinery, and equipment are all depreciated over a useful life of three to 10 years, while buildings are depreciated over a period of up to 39 years.  In general, our capitalized software is amortized over a useful life of three years, with capitalized enterprise resource planning software being amortized over a useful life of 10 years.  Gains or losses related to retirements or dispositions of fixed assets are recognized in the period incurred. 

 

            

 

Property, plant and equipment was comprised of the following (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 30,

 

March 31,

 

2013

 

2012

Land

$

23,778 

 

$

14,059 

Buildings

 

38,257 

 

 

8,351 

Furniture and fixtures

 

9,677 

 

 

4,320 

Leasehold improvements

 

1,091 

 

 

6,765 

Machinery and equipment

 

51,080 

 

 

37,481 

Capitalized software

 

24,671 

 

 

23,459 

Construction in progress

 

2,528 

 

 

28,497 

Total property, plant and equipment

 

151,082 

 

 

122,932 

Less: Accumulated depreciation and amortization

 

(50,459)

 

 

(55,954)

Property, plant and equipment, net

$

100,623 

 

$

66,978 

 

            The increase in the land and buildings balances in fiscal year 2013 was primarily attributable to the construction of the new headquarters facility, which was placed in service during fiscal year 2013, and the purchase of surrounding properties during fiscal year 2013.  Depreciation and amortization expense on property, plant, and equipment for fiscal years 2013, 2012, and 2011 was $10.2 million, $6.3 million, and $4.8 million, respectively. 

Goodwill and Intangibles, net

 

            Intangible assets include purchased technology licenses and patents that are reported at cost and are amortized on a straight-line basis over their useful lives, generally ranging from one to ten years.  Acquired intangibles include existing technology, core technology or patents, license agreements, trademarks, covenants not-to-compete and customer agreements.  These assets are amortized on a straight-line basis over lives ranging from four to fifteen years. 

 

            Goodwill is recorded at the time of an acquisition and is calculated as the difference between the aggregate consideration paid for an acquisition and the fair value of the net tangible and intangible assets acquired.  Goodwill and intangible assets deemed to have indefinite lives are not amortized but are subject to annual impairment tests.  If the assumptions and estimates used to allocate the purchase price are not correct, or if business conditions change, purchase price adjustments or future asset impairment charges could be required.  The value of our intangible assets, including goodwill, could be impacted by future adverse changes such as: (i) any future declines in our operating results, (ii) a decline in the valuation of technology company stocks, including the valuation of our common stock, (iii) a significant slowdown in the worldwide economy and the semiconductor industry, or (iv) any failure to meet the performance projections included in our forecasts of future operating results.  The Company tests goodwill and indefinite lived intangibles for impairment on an annual basis or more frequently if the Company believes indicators of impairment exist.  Impairment evaluations involve management estimates of asset useful lives and future cash flows.  Significant management judgment is required in the forecasts of future operating results that are used in the evaluations.  It is possible, however, that the plans and estimates used may be incorrect.  If our actual results, or the plans and estimates used in future impairment analysis, are lower than the original estimates used to assess the recoverability of these assets, we could incur additional impairment charges in a future period.  There are no impairments of goodwill or intangibles in 2013, 2012, and 2011.

Long-Lived Assets

 

            We test for impairment losses on long-lived assets and definite-lived intangibles used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets’ carrying amounts.  We measure any impairment loss by comparing the fair value of the asset to its carrying amount.  We estimate fair value based on discounted future cash flows, quoted market prices, or independent appraisals. 

Foreign Currency Translation

 

            All of our international subsidiaries have the U.S. dollar as the functional currency.  The local currency financial statements are remeasured into U.S. dollars using current rates of exchange for assets and liabilities.  Gains and losses from remeasurement are included in other income (expense), net.  Revenue and expenses from our international subsidiaries are remeasured using the monthly average exchange rates in effect for the period in which the items occur.  For all periods presented, our foreign currency remeasurement expense was not significant.

Concentration of Credit Risk

 

            Financial instruments that potentially subject us to material concentrations of credit risk consist primarily of cash equivalents, marketable securities, long-term marketable securities, and trade accounts receivable.  We are exposed to credit risk to the extent of the amounts recorded on the balance sheet.  By policy, our cash equivalents, marketable securities, and long-term marketable securities are subject to certain nationally recognized credit standards, issuer concentrations, sovereign risk, and marketability or liquidity considerations.

 

            In evaluating our trade receivables, we perform credit evaluations of our major customers’ financial condition and monitor closely all of our receivables to limit our financial exposure by limiting the length of time and amount of credit extended.  In certain situations, we may require payment in advance or utilize letters of credit to reduce credit risk.  By policy, we establish a reserve for trade accounts receivable based on the type of business in which a customer is engaged, the length of time a trade account receivable is outstanding, and other knowledge that we may possess relating to the probability that a trade receivable is at risk for non-payment. 

 

            For fiscal year 2013, we had three contract manufacturers, Futaihua Industrial, Hongfujin Precision and Protek, who represented 21 percent, 36 percent, and 16 percent of our consolidated gross accounts receivable, respectively.  In fiscal year 2012, we had two contract manufacturers, Futaihua Industrial and Hongfujin Precision, who represented 28 percent and 14 percent, respectively, of our consolidated gross accounts receivable.  No other distributor or customer had receivable balances that represented more than 10 percent of consolidated gross accounts receivable as of the end of fiscal year 2013 or 2012.

 

            Since the components we produce are largely proprietary and generally not available from second sources, we consider our end customer to be the entity specifying the use of our component in their design.  These end customers may then purchase our products directly from us, from a distributor, or through a third party manufacturer contracted to produce their end product.  For fiscal years 2013, 2012, and 2011, our ten largest end customers represented approximately 89 percent, 74 percent, and 62 percent of our sales, respectively.  For fiscal years 2013, 2012, and 2011, we had one end customer, Apple Inc., who purchased through multiple contract manufacturers and represented approximately 82 percent, 62 percent, and 47 percent of the Company’s total sales, respectively.  Further, we had one distributor, Avnet, Inc., that represented 15 percent, and 24 percent of our sales for fiscal years 2012, and 2011, respectively.    No other customer or distributor represented more than 10 percent of net sales in fiscal years 2013, 2012, or 2011.

Revenue Recognition

 

            We recognize revenue when all of the following criteria are met: persuasive evidence that an arrangement exists, delivery of goods has occurred, the sales price is fixed or determinable and collectability is reasonably assured.  We evaluate our distributor arrangements, on a distributor by distributor basis, with respect to each of the four criteria above.  For a majority of our distributor arrangements, we provide rights of price protection and stock rotation.  As a result, revenue is deferred at the time of shipment to our domestic distributors and certain international distributors due to the determination that the ultimate sales price to the distributor is not fixed or determinable.  Once the distributor has resold the product, and our final sales price is fixed or determinable, we recognize revenue for the final sales price and record the related costs of sales.  For certain of our smaller international distributors, we do not grant price protection rights and provide minimal stock rotation rights.  For these distributors, revenue is recognized upon delivery to the distributor, less an allowance for estimated returns, as the revenue recognition criteria have been met upon shipment. 

 

            Further, the Company defers the associated cost of goods sold on our consolidated balance sheet, net within the deferred income caption.  The Company routinely evaluates the products held by our distributors for impairment to the extent such products may be returned by the distributor within these limited rights and such products would be considered excess or obsolete if included within our own inventory.  Products returned by distributors and subsequently scrapped have historically been immaterial to the Company.

Warranty Expense

 

            We warrant our products and maintain a provision for warranty repair or replacement of shipped products.  The accrual represents management’s estimate of probable returns.  Our estimate is based on an analysis of our overall sales volume and historical claims experience, and the sales volume and historical claims experience at our largest customer, Apple, Inc.  The estimate is re-evaluated periodically for accuracy.

Shipping Costs

 

            Our shipping and handling costs are included in cost of sales for all periods presented in the Consolidated Statements of Comprehensive Income.

Advertising Costs

 

            Advertising costs are expensed as incurred.  Advertising costs were $1.5 million, $1.8 million, and $1.3 million, in fiscal years 2013, 2012, and 2011, respectively.

Stock-Based Compensation

 

            Stock-based compensation is measured at the grant date based on the grant-date fair value of the awards and is recognized as an expense, on a ratable basis, over the vesting period, which is generally between zero and four years.  Determining the amount of stock-based compensation to be recorded requires the Company to develop estimates used in calculating the grant-date fair value of stock options.  The Company calculates the grant-date fair value for stock options using the Black-Scholes valuation model.  The use of valuation models requires the Company to make estimates of assumptions such as expected volatility, expected term, risk-free interest rate, expected dividend yield, and forfeiture rates.  The grant-date fair value of restricted stock units is the market value at grant date multiplied by the number of units. 

Income Taxes

 

            We provide for the recognition of deferred tax assets if realization of such assets is more likely than not.  The Company evaluates the ability to realize its deferred tax assets based on all the facts and circumstances, including projections of future taxable income and expiration dates of carryover attributes on a quarterly basis.  We have provided a valuation allowance against a portion of our net U.S. deferred tax assets due to uncertainties regarding its realization.  The calculation of our tax liabilities involves assessing uncertainties with respect to the application of complex tax rules and the potential for future adjustment of our uncertain tax positions by the Internal Revenue Service or other taxing jurisdiction.  We recognize liabilities for uncertain tax positions based on the two-step process.  The first step requires us to determine if the weight of available evidence indicates that the tax position has met the threshold for recognition; therefore, we must evaluate whether it is more likely than not that the position will be sustained on audit, including resolution of any related appeals or litigation processes.  The second step requires us to measure the tax benefit of the tax position taken, or expected to be taken, in an income tax return as the largest amount that is more than 50 percent likely of being realized upon ultimate settlement.  We reevaluate the uncertain tax positions each quarter based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, expirations of statutes of limitation, effectively settled issues under audit, and new audit activity.  If our estimates of these taxes are greater or less than actual results, an additional tax benefit or charge will result. 

 

            Although we believe the measurement of our liabilities for uncertain tax positions is reasonable, no assurance can be given that the final outcome of these matters will not be different than what is reflected in the historical income tax provisions and accruals.  If additional taxes are assessed as a result of an audit or litigation, it could have a material effect on our income tax provision and net income in the period or periods for which that determination is made.  We operate within multiple taxing jurisdictions and are subject to audit in these jurisdictions.  These audits can involve complex issues which may require an extended period of time to resolve and could result in additional assessments of income tax. We believe adequate provisions for income taxes have been made for all periods.

 

 

Net Income Per Share

 

            Basic net income per share is based on the weighted effect of common shares issued and outstanding and is calculated by dividing net income by the basic weighted average shares outstanding during the period.  Diluted net income per share is calculated by dividing net income by the weighted average number of common shares used in the basic net income per share calculation, plus the equivalent number of common shares that would be issued assuming exercise or conversion of all potentially dilutive common shares outstanding.  These potentially dilutive items consist primarily of outstanding stock options and restricted stock awards.

 

            The following table details the calculation of basic and diluted earnings per share for fiscal years 2013, 2012, and 2011 (in thousands, except per share amounts):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Numerator:

 

 

 

 

 

 

 

 

Net income

$

136,598 

 

$

87,983 

 

$

203,503 

Denominator:

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

64,580 

 

 

64,934 

 

 

67,857 

Effect of dilutive securities

 

3,874 

 

 

3,129 

 

 

4,246 

Weighted average diluted shares

 

68,454 

 

 

68,063 

 

 

72,103 

Basic earnings per share

$

2.12 

 

$

1.35 

 

$

3.00 

Diluted earnings per share

$

2.00 

 

$

1.29 

 

$

2.82 

   

            The weighted outstanding options excluded from our diluted calculation for the years ended March 30, 2013, March 31, 2012, and March 26, 2011, were 453,000,  1,052,000,  and 615,000, respectively, as the exercise price exceeded the average market price during the period.

Accumulated Other Comprehensive Loss

 

            Our accumulated other comprehensive loss is comprised of foreign currency translation adjustments from prior years when we had subsidiaries whose functional currency was not the U.S. Dollar, as well as unrealized gains and losses on investments classified as available-for-sale.  See Note 16 – Accumulated Other Comprehensive loss for additional discussion.

Recently Issued Accounting Pronouncements

 

            In July 2012, the FASB issued ASU No. 2012-02, Intangibles – Goodwill and Other (ASC Topic 350) – Testing Indefinite-Lived Intangible Assets for Impairment.  With the amendments in this update, an entity has the option to first assess qualitative factors to determine whether it is more likely than not that indefinite-lived assets, other than goodwill, are impaired.  If, after the assessment, an entity concludes it is not more likely than not that the asset is impaired, then the entity is not required to assess further.  If an entity concludes otherwise, the fair value determination and quantitative impairment test is required, in accordance with Subtopic 350-30.  The amendments in this ASU are effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012, with early adoption permitted.  The adoption of this ASU is not expected to have a material impact on our consolidated financial position, results of operations or cash flows.

 

            In February 2013, the FASB issued ASU No. 2013-02, Comprehensive Income (ASC Topic 220) –Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income.  With the amendments in this update, an entity is required to “report the effect of significant reclassifications out of accumulated other comprehensive income on the respective line items in net income if the amount being reclassified is required under U.S. GAAP to be reclassified in its entirety to net income.  For other amounts that are not required under U.S. GAAP to be reclassified in their entirety to net income in the same reporting period, an entity is required to cross-reference other disclosures required under U.S. GAAP that provide additional detail about those amounts.”  The amendments in this ASU are effective prospectively for reporting periods beginning after December 15, 2012, with early adoption permitted.  We began complying with this ASU, as defined, in fiscal year 2013 and the adoption of this ASU currently does not, and is not expected to have a material impact on our consolidated financial position, results of operations or cash flows.

Summary Of Significant Accounting Policies (Tables)

 

 

 

 

 

 

 

 

 

 

 

 

 

March 30,

 

March 31,

 

2013

 

2012

Work in process

$

34,169 

 

$

30,921 

Finished goods

 

85,131 

 

 

24,994 

 

$

119,300 

 

$

55,915 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 30,

 

March 31,

 

2013

 

2012

Land

$

23,778 

 

$

14,059 

Buildings

 

38,257 

 

 

8,351 

Furniture and fixtures

 

9,677 

 

 

4,320 

Leasehold improvements

 

1,091 

 

 

6,765 

Machinery and equipment

 

51,080 

 

 

37,481 

Capitalized software

 

24,671 

 

 

23,459 

Construction in progress

 

2,528 

 

 

28,497 

Total property, plant and equipment

 

151,082 

 

 

122,932 

Less: Accumulated depreciation and amortization

 

(50,459)

 

 

(55,954)

Property, plant and equipment, net

$

100,623 

 

$

66,978 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Numerator:

 

 

 

 

 

 

 

 

Net income

$

136,598 

 

$

87,983 

 

$

203,503 

Denominator:

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

64,580 

 

 

64,934 

 

 

67,857 

Effect of dilutive securities

 

3,874 

 

 

3,129 

 

 

4,246 

Weighted average diluted shares

 

68,454 

 

 

68,063 

 

 

72,103 

Basic earnings per share

$

2.12 

 

$

1.35 

 

$

3.00 

Diluted earnings per share

$

2.00 

 

$

1.29 

 

$

2.82 

 

Marketable Securities (Tables)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Estimated

 

 

 

 

 

Gross

 

 

Gross

 

 

Fair Value

 

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

(Net Carrying

As of March 30, 2013

 

Cost

 

 

Gains

 

 

Losses

 

 

Amount)

Corporate debt securities

$

94,798 

 

$

 

$

(133)

 

$

94,667 

U.S. Treasury securities

 

34,380 

 

 

 

 

(3)

 

 

34,381 

Agency discount notes

 

1,027 

 

 

 -

 

 

 -

 

 

1,027 

Commercial paper

 

40,089 

 

 

 

 

(28)

 

 

40,070 

Total securities

$

170,294 

 

$

15 

 

$

(164)

 

$

170,145 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Estimated

 

 

 

Gross

 

Gross

 

Fair Value

 

Amortized

 

Unrealized

 

Unrealized

 

(Net Carrying

As of March 31, 2012

Cost

 

Gains

 

Losses

 

Amount)

Corporate debt securities

$

48,011 

 

$

33 

 

$

(19)

 

$

48,025 

U.S. Treasury securities

 

30,264 

 

 

 

 

(4)

 

 

30,261 

Agency discount notes

 

16,789 

 

 

 

 

(1)

 

 

16,796 

Commercial paper

 

23,719 

 

 

 

 

(15)

 

 

23,709 

Total securities

$

118,783 

 

$

47 

 

$

(39)

 

$

118,791 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 30, 2013

 

 

March 31, 2012

 

 

 

Amortized

 

 

Estimated

 

 

Amortized

 

 

Estimated

 

 

 

Cost

 

 

Fair Value

 

 

Cost

 

 

Fair Value

Within 1 year

 

$

105,290 

 

$

105,235 

 

$

115,871 

 

$

115,876 

After 1 year

 

 

65,004 

 

 

64,910 

 

 

2,912 

 

 

2,915 

Total

 

$

170,294 

 

$

170,145 

 

$

118,783 

 

$

118,791 

 

Fair Value Of Financial Instruments (Tables)
Schedule Of Fair Value Of Financial Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quoted Prices

 

 

 

 

 

 

 

in Active

 

Significant

 

 

 

 

 

Markets for

 

Other

 

Significant

 

 

 

Identical

 

Observable

 

Unobservable

 

 

 

Assets

 

Inputs

 

Inputs

 

 

 

Level 1

 

Level 2

 

Level 3

 

Total

Cash equivalents

 

 

 

 

 

 

 

 

 

 

 

Money market funds

$

54,762 

 

$

 -

 

$

 -

 

$

54,762 

Commercial paper

 

 -

 

 

1,500 

 

 

 -

 

 

1,500 

 

$

54,762 

 

$

1,500 

 

$

 -

 

$

56,262 

 

 

 

 

 

 

 

 

 

 

 

 

Available-for-sale securities

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

$

 -

 

$

94,667 

 

$

 -

 

$

94,667 

U.S. Treasury securities

 

34,381 

 

 

 -

 

 

 -

 

 

34,381 

Agency discount notes

 

 -

 

 

1,027 

 

 

 -

 

 

1,027 

Commercial paper

 

 -

 

 

40,070 

 

 

 -

 

 

40,070 

 

$

34,381 

 

$

135,764 

 

$

 -

 

$

170,145 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Quoted Prices

 

 

 

 

 

 

 

in Active

 

Significant

 

 

 

 

 

Markets for

 

Other

 

Significant

 

 

 

Identical

 

Observable

 

Unobservable

 

 

 

Assets

 

Inputs

 

Inputs

 

 

 

Level 1

 

Level 2

 

Level 3

 

Total

Cash equivalents

 

 

 

 

 

 

 

 

 

 

 

Money market funds

$

40,557 

 

$

 -

 

$

 -

 

$

40,557 

Commercial paper

 

 -

 

 

15,952 

 

 

 -

 

 

15,952 

Corporate debt securities

 

 -

 

 

1,112 

 

 

 -

 

 

1,112 

 

$

40,557 

 

$

17,064 

 

$

 -

 

$

57,621 

 

 

 

 

 

 

 

 

 

 

 

 

Available-for-sale securities

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

$

 -

 

$

48,025 

 

$

 -

 

$

48,025 

U.S. Treasury securities

 

30,261 

 

 

 -

 

 

 -

 

 

30,261 

Agency discount notes

 

 -

 

 

16,796 

 

 

 -

 

 

16,796 

Commercial paper

 

 -

 

 

23,709 

 

 

 -

 

 

23,709 

 

$

30,261 

 

$

88,530 

 

$

 -

 

$

118,791 

 

Accounts Receivable, Net (Tables)

 

 

 

 

 

 

 

 

 

 

 

 

 

March 30,

 

March 31,

 

2013

 

2012

Gross accounts receivable

$

69,590 

 

$

44,524 

Allowance for doubtful accounts

 

(301)

 

 

(371)

Accounts receivable, net

$

69,289 

 

$

44,153 

 

 

 

 

 

 

 

Balance, March 27, 2010

$

(488)

Bad debt expense, net of recoveries

 

67 

Balance, March 26, 2011

 

(421)

Bad debt expense, net of recoveries

 

50 

Balance, March 31, 2012

 

(371)

Bad debt expense, net of recoveries

 

70 

Balance, March 30, 2013

 

(301)

 

Goodwill And Intangibles, Net (Tables)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 30, 2013

 

 

March 31, 2012

Intangible Category (Weighted-Average Amortization period (years))

 

Gross Amount

 

 

Accumulated Amortization

 

 

Gross Amount

 

 

Accumulated Amortization

Core technology (a)

$

1,390 

 

$

(1,390)

 

$

1,390 

 

$

(1,390)

License agreement (a)

 

440 

 

 

(440)

 

 

440 

 

 

(440)

Existing technology (10.1)

 

5,566 

 

 

(3,802)

 

 

17,235 

 

 

(7,318)

Trademarks (a)(b)

 

320 

 

 

(320)

 

 

2,758 

 

 

(320)

Non-compete agreements (b)

 

 -

 

 

 -

 

 

398 

 

 

(258)

Customer relationships (b)

 

 -

 

 

 -

 

 

4,682 

 

 

(1,515)

Technology licenses (3.2)

 

16,303 

 

 

(13,417)

 

 

14,187 

 

 

(11,608)

Total

$

24,019 

 

$

(19,369)

 

$

41,090 

 

$

(22,849)

 

(a)

Intangible assets are fully amortized.

(b)

Intangible assets existing at March 31, 2012 were fully or partially removed as part of the asset sale discussed in Note 7.  

 

 

 

 

 

 

For the year ended March 29, 2014

$

2,602 

For the year ended March 28, 2015

$

1,809 

For the year ended March 26, 2016

$

218 

For the year ended March 25, 2017

$

21 

For the year ended March 31, 2018

$

 -

 

Equity Compensation (Tables)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal Years Ended

 

 

March 30, 2013

 

 

March 31, 2012

 

 

March 26, 2011

Cost of sales

$

751 

 

$

398 

 

$

243 

Research and development

 

10,549 

 

 

5,590 

 

 

2,641 

Sales, general and administrative

 

10,195 

 

 

6,190 

 

 

5,257 

Effect on pre-tax income

 

21,495 

 

 

12,178 

 

 

8,141 

Income Tax Benefit

 

(106)

 

 

 -

 

 

 -

Total share-based compensation expense (net of taxes)

 

21,389 

 

 

12,178 

 

 

8,141 

Share-based compensation effects on basic earnings per share

$

0.33 

 

$

0.19 

 

$

0.12 

Share-based compensation effects on diluted earnings per share

 

0.32 

 

 

0.18 

 

 

0.11 

Share-based compensation effects on operating activities cash flow

 

21,389 

 

 

12,178 

 

 

8,141 

Share-based compensation effects on financing activities cash flow

 

106 

 

 

 -

 

 

 -

 

 

 

 

 

 

 

 

 

Shares

 

 

Available for

 

 

Grant

Balance, March 27, 2010

 

9,930 

Plans terminated

 

(300)

Granted

 

(1,927)

Forfeited

 

472 

Balance, March 26, 2011

 

8,175 

Plans terminated

 

(34)

Granted

 

(2,049)

Forfeited

 

165 

Balance, March 31, 2012

 

6,257 

Plans terminated

 

 -

Granted

 

(1,600)

Forfeited

 

468 

Balance, March 30, 2013

 

5,125 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended

 

 

March 30, 2013

(a)

 

March 31, 2012

 

 

March 26, 2011

 

Expected stock price volatility

 

63.42

%

 

59.25 - 66.11

%

 

52.03 - 67.11

%

Risk-free interest rate

 

0.31

%

 

0.27 - 1.43

%

 

1.19 - 2.06

%

Expected term (in years)

 

2.46

 

 

2.32 - 3.82

 

 

3.83 - 4.34

 

   

(a)

 Actual assumptions at time of share issuance used.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding Options

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

Number

 

 

Exercise Price

Balance, March 27, 2010

 

10,379 

 

$

6.74 

Options granted

 

977 

 

 

16.75 

Options exercised

 

(4,718)

 

 

6.57 

Options forfeited

 

(153)

 

 

5.90 

Options expired

 

(304)

 

 

23.68 

Balance, March 26, 2011

 

6,181 

 

$

7.63 

Options granted

 

450 

 

 

15.63 

Options exercised

 

(593)

 

 

6.88 

Options forfeited

 

(67)

 

 

7.70 

Options expired

 

(67)

 

 

15.68 

Balance, March 31, 2012

 

5,904 

 

$

8.23 

Options granted

 

264 

 

 

37.22 

Options exercised

 

(1,746)

 

 

6.88 

Options forfeited

 

(144)

 

 

12.52 

Options expired

 

 -

 

 

20.25 

Balance, March 30, 2013

 

4,278 

 

$

10.42 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

Weighted Average

 

 

 

 

 

Number of

 

 

Average

 

Remaining Contractual

 

 

Aggregate

 

 

Options

 

 

Exercise price

 

Term (years)

 

 

Intrinsic Value

Vested and expected to vest

 

4,196 

 

$

10.15 

 

6.07 

 

$

56,376 

Exercisable

 

3,217 

 

$

7.76 

 

5.51 

 

$

48,228 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding

 

Options Exercisable

 

 

 

 

Weighted Average

 

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

Weighted

 

 

 

Weighted

 

 

 

 

Contractual Life

 

Average Exercise

 

Number

 

Average

Range of Exercise Prices

 

Number

 

(years)

 

Price

 

Exercisable

 

Exercise Price

$2.59 - $5.25

 

764 

 

4.78 

 

$

5.05 

 

754 

 

$

5.05 

$5.49 - $5.53

 

58 

 

6.39 

 

 

5.50 

 

44 

 

 

5.50 

$5.55 - $5.55

 

1,217 

 

6.48 

 

 

5.55 

 

961 

 

 

5.55 

$5.66 - $7.87

 

891 

 

4.10 

 

 

7.05 

 

873 

 

 

7.05 

$8.06 - $16.25

 

874 

 

7.72 

 

 

15.18 

 

434 

 

 

14.90 

$16.28 - $38.99

 

474 

 

8.11 

 

 

29.79 

 

151 

 

 

19.60 

 

 

4,278 

 

6.11 

 

$

10.42 

 

3,217 

 

$

7.76 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

Average

 

 

 

 

 

Grant Date

Aggregate

 

Number of

 

 

Fair Value

Intrinsic 

 

Shares

 

 

(per share)

value (1)

March 27, 2010

49 

 

$

6.20 

 

Granted

 

 

17.28 

 

Vested

(7)

 

 

7.35 
134 

Forfeited

(2)

 

 

7.35 

 

March 26, 2011

45 

 

 

7.21 

 

Granted

49 

 

 

15.31 

 

Vested

(54)

 

 

14.57 
826 

Forfeited

    -

 

 

    -

 

March 31, 2012

40 

 

 

7.19 

 

Granted

27 

 

 

28.24 

 

Vested

(62)

 

 

15.45 
1,657 

Forfeited

 -

 

 

 -

 

March 30, 2013

 

$

17.28 

 

 

(1)

Represents the value of Cirrus stock on the date that the restricted stock vested.

 

 

 

 

 

 

 

 

 

 

 

 

Weighted Average

 

 

 

 

Weighted

Remaining

 

 

 

 

Average

Contractual Term

 

Shares

 

 

Fair Value

(years)

March 27, 2010

 -

 

$

 -

 

Granted

628 

 

 

16.41 

 

Vested

 -

 

 

 -

 

Forfeited

(8)

 

 

16.25 

 

March 26, 2011

620 

 

 

16.41 

2.54

Granted

1,017 

 

 

16.59 

 

Vested

 -

 

 

 -

 

Forfeited

(21)

 

 

16.04 

 

March 31, 2012

1,616 

 

 

16.52 

1.94

Granted

864 

 

 

37.26 

 

Vested

(193)

 

 

20.56 

 

Forfeited

(216)

 

 

21.46 

 

March 30, 2013

2,071 

 

$

23.66 

1.57

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

Weighted Average

 

 

 

 

 

Average

 

Remaining Contractual

 

 

Shares

 

 

Fair Value

 

Term (years)

Vested and expected to vest

 

1,888

 

$

23.66

 

1.53

 

Commitments And Contingencies (Tables)
Schedule Of Future Rental Commitments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Facilities

 

 

Subleases

 

 

Net Facilities Commitments

 

 

Equipment Commitments

 

 

Total Commitments

2014

$

2,974 

 

$

112 

 

$

2,862 

 

$

11 

 

$

2,873 

2015

 

2,919 

 

 

76 

 

 

2,843 

 

 

 

 

2,848 

2016

 

2,271 

 

 

 -

 

 

2,271 

 

 

 

 

2,273 

2017

 

2,208 

 

 

 -

 

 

2,208 

 

 

 

 

2,208 

2018

 

543 

 

 

 -

 

 

543 

 

 

 -

 

 

543 

Thereafter

 

69 

 

 

 -

 

 

69 

 

 

 -

 

 

69 

Total minimum lease payment

$

10,984 

 

$

188 

 

$

10,796 

 

$

18 

 

$

10,814 

 

Accumulated Other Comprehensive Loss (Tables)
Summary Of Changes In The Components Of Accumulated Other Comprehensive Loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized Gains

 

 

 

 

 

Foreign

 

 

(Losses) on

 

 

 

 

 

Currency

 

 

Securities

 

 

Total

Balance, March 26, 2011

$

(770)

 

$

16 

 

$

(754)

Current period activity

 

 -

 

 

(8)

 

 

(8)

Balance, March 31, 2012

 

(770)

 

 

 

 

(762)

Current period activity

 

 -

 

 

(157)

 

 

(157)

Balance, March 30, 2013

$

(770)

 

$

(149)

 

$

(919)

 

Income Taxes (Tables)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended

 

March 30,

 

March 31,

 

March 26,

 

2013

 

2012

 

2011

United States

$

200,124 

 

$

79,425 

 

$

83,569 

Non-U.S.

 

1,066 

 

 

558 

 

 

645 

 

$

201,190 

 

$

79,983 

 

$

84,214 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended

 

March 30,

 

March 31,

 

March 26,

 

2013

 

2012

 

2011

Current:

 

 

 

 

 

 

 

 

Federal

$

3,537 

 

$

1,322 

 

$

163 

State

 

323 

 

 

518 

 

 

312 

Non-U.S.

 

243 

 

 

261 

 

 

204 

Total current tax provision

$

4,103 

 

$

2,101 

 

$

679 

 

 

 

 

 

 

 

 

 

Deferred:

 

 

 

 

 

 

 

 

U.S.

 

60,506 

 

 

(10,102)

 

 

(120,057)

Non-U.S.

 

(17)

 

 

 

 

89 

Total deferred tax provision (benefit)

 

60,489 

 

 

(10,101)

 

 

(119,968)

Total tax provision (benefit)

$

64,592 

 

$

(8,000)

 

$

(119,289)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended

 

March 30,

 

March 31,

 

March 26,

 

2013

 

2012

 

2011

Expected income tax provision at the U.S. federal statutory rate

 

35.0 

 

 

35.0 

 

 

35.0 

Valuation allowance changes affecting the provision of income taxes

 

(1.3)

 

 

(46.7)

 

 

(178.6)

Foreign taxes at different rates

 

(0.1)

 

 

 -

 

 

0.1 

R&D credit

 

(2.1)

 

 

 -

 

 

 -

Stock compensation

 

0.1 

 

 

1.0 

 

 

(0.1)

Nondeductible expenses

 

0.3 

 

 

0.1 

 

 

1.1 

Other

 

0.2 

 

 

0.6 

 

 

0.9 

Provision (benefit) for income taxes

 

32.1 

 

 

(10.0)

 

 

(141.6)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 30,

 

March 31,

 

2013

 

2012

Deferred tax assets:

 

 

 

 

 

Inventory valuation

$

12,065 

 

$

3,240 

Accrued expenses and allowances

 

5,077 

 

 

3,656 

Net operating loss carryforwards

 

28,162 

 

 

105,220 

Research and development tax credit carryforwards

 

37,054 

 

 

36,032 

State tax credit carryforwards

 

237 

 

 

244 

Capitalized research and development

 

6,601 

 

 

9,779 

Other

 

21,505 

 

 

18,747 

Total deferred tax assets

$

110,701 

 

$

176,918 

Valuation allowance for deferred tax assets

 

(23,232)

 

 

(29,075)

Net deferred tax assets

$

87,469 

 

$

147,843 

 

 

 

 

 

 

Deferred tax liabilities:

 

 

 

 

 

Depreciation and amortization

$

5,238 

 

$

287 

Acquisition intangibles

 

623 

 

 

5,348 

Total deferred tax liabilities

$

5,861 

 

$

5,635 

Total net deferred tax assets

$

81,608 

 

$

142,208 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 30,

 

March 31,

 

2013

 

2012

Current deferred tax assets

$

64,937 

 

$

53,137 

Long-term deferred tax assets

 

16,671 

 

 

89,071 

Total net deferred tax assets

$

81,608 

 

$

142,208 

 

 

 

 

Balance at March 31, 2012

$

 -

Additions based on tax positions related to the current year

 

 -

Reductions for tax positions of prior years

 

 -

Settlements

 

 -

Reductions related to expirations of statutes of limitation

 

 -

Balance at March 30, 2013

$

 -

 

Segment Information (Tables)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal Years Ended

 

March 30,

 

March 31,

 

March 26,

 

 

2013

 

2012

 

2011

 

Audio Products

$

754,769 

 

$

350,743 

 

$

264,840 

 

Energy Products

 

55,017 

 

 

76,100 

 

 

104,731 

 

 

$

809,786 

 

$

426,843 

 

$

369,571 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal Years Ended

 

March 30,

 

March 31,

 

March 26,

 

2013

 

2012

 

2011

United States

$

38,670 

 

$

50,230 

 

$

66,701 

United Kingdom

 

19,211 

 

 

23,927 

 

 

27,398 

China

 

700,051 

 

 

294,143 

 

 

205,775 

Hong Kong

 

8,590 

 

 

8,671 

 

 

9,216 

Japan

 

9,299 

 

 

15,196 

 

 

16,902 

South Korea

 

8,975 

 

 

9,781 

 

 

12,413 

Taiwan

 

11,694 

 

 

10,662 

 

 

13,073 

Other Asia

 

10,387 

 

 

13,063 

 

 

16,012 

Other non-U.S. countries

 

2,909 

 

 

1,170 

 

 

2,081 

Total consolidated sales

$

809,786 

 

$

426,843 

 

$

369,571 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal Years Ended

 

March 30,

 

March 31,

 

2013

 

2012

United States

$

100,343 

 

$

66,530 

United Kingdom

 

23 

 

 

20 

China

 

137 

 

 

158 

Hong Kong

 

 

 

Japan

 

25 

 

 

167 

South Korea

 

 

 

Taiwan

 

70 

 

 

83 

Other Asia

 

14 

 

 

11 

Total consolidated property, plant and equipment, net

$

100,623 

 

$

66,978 

 

Quarterly Results (Unaudited) (Tables)
Schedule Of Unaudited Quarterly Statement Of Operations Data

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal Year 2013

 

1st

 

2nd

 

3rd

 

4th

 

Quarter

 

Quarter

 

Quarter

 

Quarter

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

$

99,006 

 

$

193,774 

 

$

310,133 

 

$

206,873 

Gross margin

 

53,440 

 

 

100,087 

 

 

158,050 

 

 

83,614 

Net income

 

6,927 

 

 

35,449 

 

 

67,862 

 

 

26,360 

Basic income per share

$

0.11 

 

$

0.55 

 

$

1.04 

 

$

0.41 

Diluted income per share

 

0.10 

 

 

0.51 

 

 

0.99 

 

 

0.39 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fiscal Year 2012

 

1st

 

2nd

 

3rd

 

4th

 

Quarter

 

Quarter

 

Quarter

 

Quarter

 

 

 

 

 

 

 

 

 

 

 

(1)

Net sales

$

92,242 

 

$

101,602 

 

$

122,368 

 

$

110,631 

Gross margin

 

47,709 

 

 

54,355 

 

 

66,030 

 

 

62,347 

Net income

 

9,178 

 

 

11,247 

 

 

16,731 

 

 

50,827 

Basic income per share

$

0.14 

 

$

0.17 

 

$

0.26 

 

$

0.79 

Diluted income per share

 

0.13 

 

 

0.17 

 

 

0.25 

 

 

0.75 

 

The $39.5 million tax benefit recorded in the fourth quarter of 2012 favorably impacted net income, as a result of a $37.3 million release in valuation allowance on deferred tax assets.

Summary Of Significant Accounting Policies (Narrative) (Details) (USD $)
12 Months Ended
Mar. 30, 2013
Mar. 31, 2012
Mar. 26, 2011
Depreciation and amortization expense on property, plant and equipment
$ 13,562,000 
$ 9,972,000 
$ 8,145,000 
Impairment of goodwill
Advertising expense
1,500,000 
1,800,000 
1,300,000 
Weighted outstanding options excluded from diluted calculation
453,000 
1,052,000 
615,000 
Maximum [Member]
 
 
 
Intangible assets, useful life
10 years 
 
 
Acquired intangible assets, useful life
15 years 
 
 
Share-based compensation, vesting period
4 years 
 
 
Minimum [Member]
 
 
 
Intangible assets, useful life
1 year 
 
 
Acquired intangible assets, useful life
4 years 
 
 
Share-based compensation, vesting period
0 years 
 
 
Buildings [Member] |
Maximum [Member]
 
 
 
Estimated useful life
39 years 
 
 
Software [Member]
 
 
 
Estimated useful life
3 years 
 
 
Furniture, Fixtures, Machinery And Equipment [Member] |
Maximum [Member]
 
 
 
Estimated useful life
10 years 
 
 
Furniture, Fixtures, Machinery And Equipment [Member] |
Minimum [Member]
 
 
 
Estimated useful life
3 years 
 
 
Capitalized Enterprise Resource Planning Software [Member]
 
 
 
Estimated useful life
10 years 
 
 
Property, Plant And Equipment [Member]
 
 
 
Depreciation and amortization expense on property, plant and equipment
$ 10,200,000 
$ 6,300,000 
$ 4,800,000 
Property, Plant And Equipment [Member] |
Maximum [Member]
 
 
 
Estimated useful life
39 years 
 
 
Property, Plant And Equipment [Member] |
Minimum [Member]
 
 
 
Estimated useful life
3 years 
 
 
Futaihua Industrial [Member] |
Accounts Receivable [Member]
 
 
 
Concentration risk, percentage
21.00% 
28.00% 
 
Hongfujin Precision [Member] |
Accounts Receivable [Member]
 
 
 
Concentration risk, percentage
36.00% 
14.00% 
 
Protek [Member] |
Accounts Receivable [Member]
 
 
 
Concentration risk, percentage
16.00% 
 
 
Avnet, Inc. [Member] |
Sales [Member]
 
 
 
Concentration risk, percentage
 
15.00% 
24.00% 
Apple, Inc. [Member] |
Sales [Member]
 
 
 
Concentration risk, percentage
82.00% 
62.00% 
47.00% 
No Other Distributor [Member] |
Maximum [Member] |
Accounts Receivable [Member]
 
 
 
Concentration risk, percentage
10.00% 
10.00% 
 
Ten Largest Customers [Member]
 
 
 
Number of customers responsible for sales concentration
 
10 
 
Ten Largest Customers [Member] |
Sales [Member]
 
 
 
Concentration risk, percentage
89.00% 
74.00% 
62.00% 
No Other Customer Or Distributor [Member] |
Maximum [Member] |
Sales [Member]
 
 
 
Concentration risk, percentage
10.00% 
10.00% 
10.00% 
Summary Of Significant Accounting Policies (Schedule Of Inventories) (Details) (USD $)
In Thousands, unless otherwise specified
Mar. 30, 2013
Mar. 31, 2012
Summary Of Significant Accounting Policies [Abstract]
 
 
Work in process
$ 34,169 
$ 30,921 
Finished goods
85,131 
24,994 
Total inventories
$ 119,300 
$ 55,915 
Summary Of Significant Accounting Policies (Components Of Property, Plant And Equipment) (Details) (USD $)
In Thousands, unless otherwise specified
Mar. 30, 2013
Mar. 31, 2012
Property, Plant and Equipment [Line Items]
 
 
Total property, plant and equipment
$ 151,082 
$ 122,932 
Less: Accumulated depreciation and amortization
(50,459)
(55,954)
Property, plant and equipment, net
100,623 
66,978 
Land [Member]
 
 
Property, Plant and Equipment [Line Items]
 
 
Total property, plant and equipment
23,778 
14,059 
Buildings [Member]
 
 
Property, Plant and Equipment [Line Items]
 
 
Total property, plant and equipment
38,257 
8,351 
Furniture And Fixtures [Member]
 
 
Property, Plant and Equipment [Line Items]
 
 
Total property, plant and equipment
9,677 
4,320 
Leasehold Improvements [Member]
 
 
Property, Plant and Equipment [Line Items]
 
 
Total property, plant and equipment
1,091 
6,765 
Machinery And Equipment [Member]
 
 
Property, Plant and Equipment [Line Items]
 
 
Total property, plant and equipment
51,080 
37,481 
Capitalized Software [Member]
 
 
Property, Plant and Equipment [Line Items]
 
 
Total property, plant and equipment
24,671 
23,459 
Construction In Progress [Member]
 
 
Property, Plant and Equipment [Line Items]
 
 
Total property, plant and equipment
$ 2,528 
$ 28,497 
Summary Of Significant Accounting Policies (Calculation Of Basic And Diluted Earnings Per Share) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 12 Months Ended
Mar. 30, 2013
Dec. 29, 2012
Sep. 29, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 24, 2011
Jun. 25, 2011
Mar. 30, 2013
Mar. 31, 2012
Mar. 26, 2011
Summary Of Significant Accounting Policies [Abstract]
 
 
 
 
 
 
 
 
 
 
 
Net income
$ 26,360 
$ 67,862 
$ 35,449 
$ 6,927 
$ 50,827 1
$ 16,731 
$ 11,247 
$ 9,178 
$ 136,598 
$ 87,983 
$ 203,503 
Weighted average shares outstanding
 
 
 
 
 
 
 
 
64,580 
64,934 
67,857 
Effect of dilutive securities
 
 
 
 
 
 
 
 
3,874 
3,129 
4,246 
Weighted average diluted shares
 
 
 
 
 
 
 
 
68,454 
68,063 
72,103 
Basic earnings per share
$ 0.41 
$ 1.04 
$ 0.55 
$ 0.11 
$ 0.79 1
$ 0.26 
$ 0.17 
$ 0.14 
$ 2.12 
$ 1.35 
$ 3.00 
Diluted earnings per share
$ 0.39 
$ 0.99 
$ 0.51 
$ 0.10 
$ 0.75 1
$ 0.25 
$ 0.17 
$ 0.13 
$ 2.00 
$ 1.29 
$ 2.82 
Marketable Securities (Narrative) (Details) (USD $)
Mar. 30, 2013
security
Mar. 31, 2012
security
Marketable Securities [Abstract]
 
 
Minimum maturity period of investments to be classified as available-for-sale securities
90 days 
 
Gross unrealized losses
$ 164,000 
$ 39,000 
Amortized cost on available for sale securities held at gross unrealized losses
$ 124,100,000 
$ 72,600,000 
Number of securities
43 
37 
Marketable Securities (Schedule Of Available-for-sale Securities) (Details) (USD $)
In Thousands, unless otherwise specified
Mar. 30, 2013
Mar. 31, 2012
Schedule of Available-for-sale Securities [Line Items]
 
 
Amortized Cost
$ 170,294 
$ 118,783 
Gross Unrealized Gains
15 
47 
Gross Unrealized Losses
(164)
(39)
Estimated Fair Value (Net Carrying Amount)
170,145 
118,791 
Corporate Debt Securities - U.S. [Member]
 
 
Schedule of Available-for-sale Securities [Line Items]
 
 
Amortized Cost
94,798 
48,011 
Gross Unrealized Gains
33 
Gross Unrealized Losses
(133)
(19)
Estimated Fair Value (Net Carrying Amount)
94,667 
48,025 
U.S. Treasury Securities [Member]
 
 
Schedule of Available-for-sale Securities [Line Items]
 
 
Amortized Cost
34,380 
30,264 
Gross Unrealized Gains
Gross Unrealized Losses
(3)
(4)
Estimated Fair Value (Net Carrying Amount)
34,381 
30,261 
Agency Discount Notes [Member]
 
 
Schedule of Available-for-sale Securities [Line Items]
 
 
Amortized Cost
1,027 
16,789 
Gross Unrealized Gains
 
Gross Unrealized Losses
 
(1)
Estimated Fair Value (Net Carrying Amount)
1,027 
16,796 
Commercial Paper [Member]
 
 
Schedule of Available-for-sale Securities [Line Items]
 
 
Amortized Cost
40,089 
23,719 
Gross Unrealized Gains
Gross Unrealized Losses
(28)
(15)
Estimated Fair Value (Net Carrying Amount)
$ 40,070 
$ 23,709 
Marketable Securities (Schedule of Cost And Estimated Fair Value Of Available-for-sale Securities By Contractual Maturity) (Details) (USD $)
In Thousands, unless otherwise specified
Mar. 30, 2013
Mar. 31, 2012
Marketable Securities [Abstract]
 
 
Within 1 year, Amortized Cost
$ 105,290 
$ 115,871 
After 1 year, Amortized Cost
65,004 
2,912 
Within 1 year, Estimated Fair Value
105,235 
115,876 
After 1 year, Estimated Fair Value
64,910 
2,915 
Amortized Cost
170,294 
118,783 
Estimated Fair Value
$ 170,145 
$ 118,791 
Fair Value Of Financial Instruments (Schedule Of Fair Value Of Financial Assets) (Details) (USD $)
In Thousands, unless otherwise specified
Mar. 30, 2013
Mar. 31, 2012
Cash Equivalents [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
$ 56,262 
$ 57,621 
Cash Equivalents [Member] |
Quoted Prices In Active Markets For Identical Assets Level 1 [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
54,762 
40,557 
Cash Equivalents [Member] |
Significant Other Observable Inputs Level 2 [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
1,500 
17,064 
Cash Equivalents [Member] |
Corporate Debt Securities [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
 
1,112 
Cash Equivalents [Member] |
Corporate Debt Securities [Member] |
Significant Other Observable Inputs Level 2 [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
 
1,112 
Cash Equivalents [Member] |
Money-Market Funds [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
54,762 
40,557 
Cash Equivalents [Member] |
Money-Market Funds [Member] |
Quoted Prices In Active Markets For Identical Assets Level 1 [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
54,762 
40,557 
Cash Equivalents [Member] |
Commercial Paper [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
1,500 
15,952 
Cash Equivalents [Member] |
Commercial Paper [Member] |
Significant Other Observable Inputs Level 2 [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
1,500 
15,952 
Available-for-sale Securities [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
170,145 
118,791 
Available-for-sale Securities [Member] |
Quoted Prices In Active Markets For Identical Assets Level 1 [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
34,381 
30,261 
Available-for-sale Securities [Member] |
Significant Other Observable Inputs Level 2 [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
135,764 
88,530 
Available-for-sale Securities [Member] |
Corporate Debt Securities [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
94,667 
48,025 
Available-for-sale Securities [Member] |
Corporate Debt Securities [Member] |
Significant Other Observable Inputs Level 2 [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
94,667 
48,025 
Available-for-sale Securities [Member] |
U.S. Treasury Securities [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
34,381 
30,261 
Available-for-sale Securities [Member] |
U.S. Treasury Securities [Member] |
Quoted Prices In Active Markets For Identical Assets Level 1 [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
34,381 
30,261 
Available-for-sale Securities [Member] |
Agency Discount Notes [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
1,027 
16,796 
Available-for-sale Securities [Member] |
Agency Discount Notes [Member] |
Significant Other Observable Inputs Level 2 [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
1,027 
16,796 
Available-for-sale Securities [Member] |
Commercial Paper [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
40,070 
23,709 
Available-for-sale Securities [Member] |
Commercial Paper [Member] |
Significant Other Observable Inputs Level 2 [Member]
 
 
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
 
 
Fair value of financial assets
$ 40,070 
$ 23,709 
Accounts Receivable, Net (Components Of Accounts Receivable, Net) (Details) (USD $)
In Thousands, unless otherwise specified
Mar. 30, 2013
Mar. 31, 2012
Mar. 26, 2011
Mar. 27, 2010
Accounts Receivable, Net [Abstract]
 
 
 
 
Gross accounts receivable
$ 69,590 
$ 44,524 
 
 
Allowance for doubtful accounts
(301)
(371)
(421)
(488)
Accounts receivable, net
$ 69,289 
$ 44,153 
 
 
Accounts Receivable, Net (Changes In the Allowance For Doubtful Accounts) (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Mar. 30, 2013
Mar. 31, 2012
Mar. 26, 2011
Accounts Receivable, Net [Abstract]
 
 
 
Balance
$ (371)
$ (421)
$ (488)
Bad debt expense, net of recoveries
70 
50 
67 
Balance
$ (301)
$ (371)
$ (421)
Goodwill And Intangibles, Net (Narrative) (Details) (USD $)
In Millions, unless otherwise specified
Mar. 30, 2013
Mar. 31, 2012
Goodwill And Intangibles, Net [Abstract]
 
 
Goodwill
$ 6.0 
$ 6.0 
Goodwill And Intangibles, Net (Schedule Of Gross Carrying Amount And Amortization Of Intangible Assets) (Details) (USD $)
In Thousands, unless otherwise specified
Mar. 30, 2013
Mar. 31, 2012
Finite-Lived Intangible Assets [Line Items]
 
 
Gross Amount
$ 24,019 
$ 41,090 
Accumulated Amortization
(19,369)
(22,849)
Core Technology [Member]
 
 
Finite-Lived Intangible Assets [Line Items]
 
 
Gross Amount
1,390 1
1,390 1
Accumulated Amortization
(1,390)1
(1,390)1
License Agreement [Member]
 
 
Finite-Lived Intangible Assets [Line Items]
 
 
Gross Amount
440 1
440 1
Accumulated Amortization
(440)1
(440)1
Existing Technology [Member]
 
 
Finite-Lived Intangible Assets [Line Items]
 
 
Gross Amount
5,566 
17,235 
Accumulated Amortization
(3,802)
(7,318)
Trademarks [Member]
 
 
Finite-Lived Intangible Assets [Line Items]
 
 
Gross Amount
320 1 2
2,758 1 2
Accumulated Amortization
(320)1 2
(320)1 2
Non-compete Agreements [Member]
 
 
Finite-Lived Intangible Assets [Line Items]
 
 
Gross Amount
 
398 2
Accumulated Amortization
 
(258)2
Customer Relationships [Member]
 
 
Finite-Lived Intangible Assets [Line Items]
 
 
Gross Amount
 
4,682 2
Accumulated Amortization
 
(1,515)2
Technology Licenses [Member]
 
 
Finite-Lived Intangible Assets [Line Items]
 
 
Gross Amount
16,303 
14,187 
Accumulated Amortization
$ (13,417)
$ (11,608)
Goodwill And Intangibles, Net (Schedule Of Estimated Aggregate Amortization Expense For Intangibles) (Details) (USD $)
12 Months Ended
Mar. 30, 2013
Mar. 31, 2012
Mar. 26, 2011
Goodwill And Intangibles, Net [Abstract]
 
 
 
Amortization expense for all intangibles
$ 3,400,000 
$ 3,700,000 
$ 3,300,000 
Estimated aggregate amortization expense for the year ended March 29, 2014
2,602,000 
 
 
Estimated aggregate amortization expense for the year ended March 28, 2015
1,809,000 
 
 
Estimated aggregate amortization expense for the year ended March 26, 2016
218,000 
 
 
Estimated aggregate amortization expense for the year ended March 25, 2017
21,000 
 
 
Estimated aggregate amortization expense for the year ended March 31, 2018
$ 0 
 
 
Asset Sale (Narrative) (Details) (USD $)
12 Months Ended
Mar. 30, 2013
Aug. 17, 2012
Asset Sale [Abstract]
 
 
Disposition Price of Other Productive Assets Sold
 
$ 26,100,000 
Proceeds from Sale of Other Productive Assets
22,220,000 
 
Nontrade Receivables, Noncurrent
 
3,900,000 
Gain on sale of asset
$ 200,000 
 
Revolving Line Of Credit (Narrative) (Details) (USD $)
12 Months Ended
Mar. 30, 2013
Line Of Credit [Abstract]
 
Borrowing limit under the unsecured revolving credit facility
$ 100,000,000 
Revolving credit sublimit
15,000,000 
Basis spread on variable interest rate
0.50% 
Covenant Terms, Leverage Ratio Requirement
175.00% 
Covenant Terms, Interest Coverage Ratio
350.00% 
Line of Credit Facility, Amount Outstanding
Line of Credit Facility, Increase (Decrease) for Period, Net
$ 0 
Restructuring Costs (Details) (USD $)
12 Months Ended
Mar. 30, 2013
employee
Restructuring Costs [Abstract]
 
Restructuring and Related Cost, Number of Positions Eliminated
25 
Restructuring and Related Cost, Number of Positions Eliminated, Period Percent
4.00% 
Restructuring And Related Cost Number Of Positions Relocated
20 
Restructuring and other, net
$ 3,292,000 
Business Exit Costs
1,100,000 
Other Restructuring Costs
2,400,000 
Restructuring expense paid
2,000,000 
Payments for severance and relocation-related costs
900,000 
Asset impairment charge
1,000,000 
Facility related costs incurred
100,000 
Remaining restructuring accrual
$ 1,500,000 
Employee Benefit Plans (Details) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Mar. 30, 2013
Mar. 31, 2012
Mar. 26, 2011
Employee Benefit Plans [Abstract]
 
 
 
Maximum percentage of contribution match of the first 6% of employees' annual contribution
50.00% 
 
 
Matching contribution percentage of gross annual contribution amount
6.00% 
 
 
Employee matching contribution expense
$ 1.5 
$ 1.3 
$ 1.0 
Equity Compensation (Narrative) (Details) (USD $)
12 Months Ended
Mar. 30, 2013
Mar. 31, 2012
Mar. 26, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
 
 
 
Share based compensation effects on operating activities cash flow
$ 21,495,000 
$ 12,178,000 
$ 8,141,000 
Compensation costs related to equity incentive plans not yet recognized
39,700,000 
 
 
Weighted average exercise price, options granted
$ 37.22 
$ 15.63 
$ 16.75 
Net amount received from exercise of stock options granted
12,000,000 
4,100,000 
31,000,000 
Number, exercised
1,746,000 
593,000 
4,718,000 
Total intrinsic value of stock options exercised
48,600,000 
7,600,000 
50,400,000 
Shares reserved for issuance under the Stock Option Plans
9,400,000 
 
 
Fair value of options that became vested during the period
4,800,000 
6,300,000 
6,000,000 
Number of options exercisable
3,217,000 
3,800,000 
 
Stock Options [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
 
 
 
Share based compensation, period from grant date options are exercisable
10 years 
 
 
Compensation costs related to equity incentive plans, weighted average recognition period
11 months 16 days 
 
 
Restricted Stock Awards [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
 
 
 
Compensation costs related to equity incentive plans, weighted average recognition period
1 year 3 months 7 days 
 
 
Shares reserved for issuance under the Stock Option Plans
100,000 
 
 
Shares available for grant reduction ratio
1.5 
 
 
Fair value of awards vested
951,000 
637,000 
37,000 
Restricted Stock Units (RSUs) [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
 
 
 
Compensation costs related to equity incentive plans, weighted average recognition period
1 year 6 months 26 days 
 
 
Shares reserved for issuance under the Stock Option Plans
3,200,000 
 
 
Vesting percentage
100.00% 
 
 
Shares available for grant reduction ratio
1.5 
 
 
Fair value of awards vested
3,800,000 
Decrease in shares authorized and unissued share balance
200,000 
 
 
Increase in outstanding share balance
100,000 
 
 
Payment and subsequent retirement of of shares
1,700,000 
 
 
Restricted Stock Awards And Restricted Stock Units [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
 
 
 
Share based compensation effects on operating activities cash flow
$ 16,300,000 
$ 6,300,000 
$ 1,100,000 
Maximum [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
 
 
 
Share-based compensation, vesting period
4 years 
 
 
Maximum [Member] |
Stock Options [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
 
 
 
Share-based compensation, vesting period
4 years 
 
 
Maximum [Member] |
Restricted Stock Awards [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
 
 
 
Share-based compensation, vesting period
4 years 
 
 
Maximum [Member] |
Restricted Stock Units (RSUs) [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
 
 
 
Share-based compensation, vesting period
3 years 
 
 
Minimum [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
 
 
 
Share-based compensation, vesting period
0 years 
 
 
Minimum [Member] |
Stock Options [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
 
 
 
Share-based compensation, vesting period
0 years 
 
 
Minimum [Member] |
Restricted Stock Units (RSUs) [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
 
 
 
Share-based compensation, vesting period
1 year 
 
 
Weighted Average Estimated Fair Value Using Black-Scholes Option Valuation Model [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
 
 
 
Fair value of stock options granted under the Black-Scholes valuation model
$ 20.43 
$ 7.58 
$ 9.61 
Equity Compensation (Summary Of Activity In Total Stock Available for Grant) (Details)
In Thousands, unless otherwise specified
12 Months Ended
Mar. 30, 2013
Mar. 31, 2012
Mar. 26, 2011
Equity Compensation [Abstract]
 
 
 
Shares available for grant, beginning balance
6,257 
8,175 
9,930 
Shares available for grant, terminated
 
(34)
(300)
Shares available for grant, granted
(1,600)
(2,049)
(1,927)
Shares available for grant, forfeited
468 
165 
472 
Shares available for grant, ending balance
5,125 
6,257 
8,175 
Equity Compensation (Summary Of Effect Of Stock-Based Compensation On Cost Of Goods Sold) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Mar. 30, 2013
Mar. 31, 2012
Mar. 26, 2011
Effect on pre-tax income
$ 21,495 
$ 12,178 
$ 8,141 
Income Tax Benefit
(106)
 
 
Total share based compensation expense (net of taxes)
21,389 
12,178 
8,141 
Share based compensation effects on basic earnings (loss) per share
$ 0.33 
$ 0.19 
$ 0.12 
Share based compensation effects on diluted earnings (loss) per share
$ 0.32 
$ 0.18 
$ 0.11 
Share based compensation effects on operating activities cash flow
21,389 
12,178 
8,141 
Share based compensation effects on financing activities cash flow
106 
 
 
Cost of Sales [Member]
 
 
 
Effect on pre-tax income
751 
398 
243 
Research and Development [Member]
 
 
 
Effect on pre-tax income
10,549 
5,590 
2,641 
Selling, General and Administrative [Member]
 
 
 
Effect on pre-tax income
$ 10,195 
$ 6,190 
$ 5,257 
Equity Compensation (Schedule Of Fair Value Of Stock Option Grants) (Details)
12 Months Ended
Mar. 30, 2013
Mar. 31, 2012
Mar. 26, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
 
 
 
Expected stock price volatility
63.42% 1
 
 
Expected stock price volatility, minimum
 
59.25% 
52.03% 
Expected stock price volatility, maximum
 
66.11% 
67.11% 
Risk-free interest rate
0.31% 1
 
 
Risk-free interest rate, minimum
 
0.27% 
1.19% 
Risk-free interest rate, maximum
 
1.43% 
2.06% 
Expected term
2 years 5 months 16 days 1
 
 
Maximum [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
 
 
 
Expected term
 
3 years 9 months 26 days 
4 years 4 months 2 days 
Minimum [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
 
 
 
Expected term
 
2 years 3 months 26 days 
3 years 9 months 29 days 
Equity Compensation (Schedule Of Stock Option Activity) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Mar. 30, 2013
Mar. 31, 2012
Mar. 26, 2011
Equity Compensation [Abstract]
 
 
 
Number, beginning balance
5,904 
6,181 
10,379 
Number, granted
264 
450 
977 
Number, exercised
(1,746)
(593)
(4,718)
Number, forfeited
(144)
(67)
(153)
Number, expired
 
(67)
(304)
Number, ending balance
4,278 
5,904 
6,181 
Weighted average exercise price, beginning balance
$ 8.23 
$ 7.63 
$ 6.74 
Weighted average exercise price, options granted
$ 37.22 
$ 15.63 
$ 16.75 
Weighted average exercise price, options exercised
$ 6.88 
$ 6.88 
$ 6.57 
Weighted average exercise price, options forfeited
$ 12.52 
$ 7.70 
$ 5.90 
Weighted average exercise price, options expired
$ 20.25 
$ 15.68 
$ 23.68 
Weighted average exercise price, ending balance
$ 10.42 
$ 8.23 
$ 7.63 
Equity Compensation (Summary Of Outstanding Options Vesting, Expected To Vest, Or Exercisable) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Mar. 30, 2013
Mar. 31, 2012
Equity Compensation [Abstract]
 
 
Number of Options, Vested and expected to vest
4,196 
 
Weighted Average Exercise Price, Vested and expected to vest
$ 10.15 
 
Weighted Average Remaining Contractual Term, Vested and expected to vest
6 years 26 days 
 
Aggregate Intrinsic Value, Vested and expected to vest
$ 56,376 
 
Number of Options, Exercisable
3,217 
3,800 
Weighted Average Exercise Price, Exercisable
$ 7.76 
 
Weighted Average Remaining Contractual Term, Exercisable
5 years 6 months 4 days 
 
Aggregate Intrinsic Value, Exercisable
$ 48,228 
 
Equity Compensation (Summary Of Outstanding And Exercisable Options) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Mar. 30, 2013
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
 
Options Outstanding, Number
4,278 
Options Outstanding, Weighted Average Remaining Contractual Life
6 years 1 month 10 days 
Options Outstanding, Weighted Average Exercise Price
$ 10.42 
Options Exercisable, Number Exercisable
3,217 
Options Exercisable, Weighted Average Exercise Price
$ 7.76 
$2.59 - $5.25 [Member]
 
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
 
Range of Exercise Prices, lower limit
$ 2.59 
Range of Exercise Prices, upper limit
$ 5.25 
Options Outstanding, Number
764 
Options Outstanding, Weighted Average Remaining Contractual Life
4 years 9 months 11 days 
Options Outstanding, Weighted Average Exercise Price
$ 5.05 
Options Exercisable, Number Exercisable
754 
Options Exercisable, Weighted Average Exercise Price
$ 5.05 
$5.49 - $5.53 [Member]
 
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
 
Range of Exercise Prices, lower limit
$ 5.49 
Range of Exercise Prices, upper limit
$ 5.53 
Options Outstanding, Number
58 
Options Outstanding, Weighted Average Remaining Contractual Life
6 years 4 months 21 days 
Options Outstanding, Weighted Average Exercise Price
$ 5.50 
Options Exercisable, Number Exercisable
44 
Options Exercisable, Weighted Average Exercise Price
$ 5.50 
$5.55 - $5.55 [Member]
 
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
 
Range of Exercise Prices, lower limit
$ 5.55 
Range of Exercise Prices, upper limit
$ 5.55 
Options Outstanding, Number
1,217 
Options Outstanding, Weighted Average Remaining Contractual Life
6 years 5 months 23 days 
Options Outstanding, Weighted Average Exercise Price
$ 5.55 
Options Exercisable, Number Exercisable
961 
Options Exercisable, Weighted Average Exercise Price
$ 5.55 
$5.66 - $7.87 [Member]
 
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
 
Range of Exercise Prices, lower limit
$ 5.66 
Range of Exercise Prices, upper limit
$ 7.87 
Options Outstanding, Number
891 
Options Outstanding, Weighted Average Remaining Contractual Life
4 years 1 month 6 days 
Options Outstanding, Weighted Average Exercise Price
$ 7.05 
Options Exercisable, Number Exercisable
873 
Options Exercisable, Weighted Average Exercise Price
$ 7.05 
$8.06 - $16.25 [Member]
 
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
 
Range of Exercise Prices, lower limit
$ 8.06 
Range of Exercise Prices, upper limit
$ 16.25 
Options Outstanding, Number
874 
Options Outstanding, Weighted Average Remaining Contractual Life
7 years 8 months 19 days 
Options Outstanding, Weighted Average Exercise Price
$ 15.18 
Options Exercisable, Number Exercisable
434 
Options Exercisable, Weighted Average Exercise Price
$ 14.90 
$16.28 - $38.99 [Member]
 
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
 
Range of Exercise Prices, lower limit
$ 16.28 
Range of Exercise Prices, upper limit
$ 38.99 
Options Outstanding, Number
474 
Options Outstanding, Weighted Average Remaining Contractual Life
8 years 1 month 10 days 
Options Outstanding, Weighted Average Exercise Price
$ 29.79 
Options Exercisable, Number Exercisable
151 
Options Exercisable, Weighted Average Exercise Price
$ 19.60 
Equity Compensation (Summary Of Restricted Stock Award Activity) (Details) (Restricted Stock Awards [Member], USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Mar. 30, 2013
Mar. 31, 2012
Mar. 26, 2011
Restricted Stock Awards [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
 
 
 
Number of Shares, Balance
40 
45 
49 
Number of Shares, Granted
27 
49 
Number of Shares, Vested
(62)
(54)
(7)
Number of Shares, Forfeited
 
 
(2)
Number of Shares, Balance
40 
45 
Weighted Average Grant Date Fair Value (per share), Balance
$ 7.19 
$ 7.21 
$ 6.20 
Weighted Average Grant Date Fair Value (per share), Granted
$ 28.24 
$ 15.31 
$ 17.28 
Weighted Average Grant Date Fair Value (per share), Vested
$ 15.45 
$ 14.57 
$ 7.35 
Weighted Average Grant Date Fair Value (per share), Forfeited
 
 
$ 7.35 
Weighted Average Grant Date Fair Value (per share), Balance
$ 17.28 
$ 7.19 
$ 7.21 
Aggregate Intrinsic value, Vested
$ 1,657 1
$ 826 1
$ 134 1
Equity Compensation (Summary Of Restricted Stock Unit Activity) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Mar. 30, 2013
Mar. 31, 2012
Mar. 26, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
 
 
 
Shares, Vested and expected to vest
4,196 
 
 
Weighted Average Exercise Price, Vested and expected to vest
$ 10.15 
 
 
Weighted Average Remaining Contractual Term, Vested and expected to vest
6 years 26 days 
 
 
Restricted Stock Units (RSUs) [Member]
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
 
 
 
Number of Shares, Balance
1,616 
620 
 
Number of Shares, Granted
864 
1,017 
628 
Number of Shares, Vested
(193)
 
 
Number of Shares, Forfeited
(216)
(21)
(8)
Number of Shares, Balance
2,071 
1,616 
620 
Weighted Average Grant Date Fair Value (per share), Balance
$ 16.52 
$ 16.41 
 
Weighted Average Grant Date Fair Value (per share), Granted
$ 37.26 
$ 16.59 
$ 16.41 
Weighted Average Grant Date Fair Value (per share), Vested
$ 20.56 
 
 
Weighted Average Grant Date Fair Value (per share), Forfeited
$ 21.46 
$ 16.04 
$ 16.25 
Weighted Average Grant Date Fair Value (per share), Balance
$ 23.66 
$ 16.52 
$ 16.41 
Weighted Average Remaining Contractual Term
1 year 6 months 26 days 
1 year 11 months 9 days 
2 years 6 months 15 days 
Shares, Vested and expected to vest
1,888 
 
 
Weighted Average Exercise Price, Vested and expected to vest
$ 23.66 
 
 
Weighted Average Remaining Contractual Term, Vested and expected to vest
1 year 6 months 11 days 
 
 
Commitments And Contingencies (Narrative) (Details) (USD $)
In Millions, unless otherwise specified
12 Months Ended 12 Months Ended
Mar. 30, 2013
Mar. 31, 2012
Mar. 26, 2011
Mar. 30, 2013
Tucson, Arizona Facility [Member]
sqft
Mar. 30, 2013
Capacity Investment And Loading Agreement With STATS ChipPAC Ltd [Member]
Jan. 24, 2012
Capacity Investment And Loading Agreement With STATS ChipPAC Ltd [Member]
Dec. 22, 2011
Capacity Investment And Loading Agreement With STATS ChipPAC Ltd [Member]
Mar. 30, 2013
Foundry Commitments [Member]
Mar. 30, 2013
Assembly Purchase Order Commitments [Member]
Mar. 30, 2013
Outside Test Services Commitments [Member]
Purchase Commitment, Excluding Long-term Commitment [Line Items]
 
 
 
 
 
 
 
 
 
 
Square footage of Tucson facilities
 
 
 
28,000 
 
 
 
 
 
 
Rent expense
$ 3.2 
$ 4.7 
$ 4.6 
 
 
 
 
 
 
 
Sublease rental income
0.1 
0.4 
1.1 
 
 
 
 
 
 
 
Non-cancelable purchase commitments
 
 
 
 
 
 
10.0 
31.0 
2.3 
1.1 
Purchase commitment, initial payment
 
 
 
 
 
 
 
 
 
Purchase commitment, remaining amount
 
 
 
 
 
 
 
 
 
Purchase commitment, rebate amount
 
 
 
 
10 
 
 
 
 
 
Purchase commitment, expected rebate to receive
 
 
 
 
10 
 
 
 
 
 
Purchase obligation, rebate utilized
 
 
 
 
$ 4.3 
 
 
 
 
 
Commitments And Contingencies (Schedule Of Future Rental Commitments) (Details) (USD $)
In Thousands, unless otherwise specified
Mar. 30, 2013
Rental Commitments [Line Items]
 
2014
$ 2,873 
2015
2,848 
2016
2,273 
2017
2,208 
2018
543 
Thereafter
69 
Total minimum lease payment
10,814 
Facilities [Member]
 
Rental Commitments [Line Items]
 
2014
2,974 
2015
2,919 
2016
2,271 
2017
2,208 
2018
543 
Thereafter
69 
Total minimum lease payment
10,984 
Subleases [Member]
 
Rental Commitments [Line Items]
 
2014
112 
2015
76 
2016
2017
2018
Thereafter
Total minimum lease payment
188 
Net Facilities Commitments [Member]
 
Rental Commitments [Line Items]
 
2014
2,862 
2015
2,843 
2016
2,271 
2017
2,208 
2018
543 
Thereafter
69 
Total minimum lease payment
10,796 
Equipment Commitments [Member]
 
Rental Commitments [Line Items]
 
2014
11 
2015
2016
2017
2018
Thereafter
Total minimum lease payment
$ 18 
Legal Matters (Details)
12 Months Ended
Mar. 30, 2013
item
defendant
Legal Matters [Abstract]
 
Number of U.S.Ethernet Innovations lawsuit co-defendants
Number of patents allegedly infringed upon
Patent Agreement, Net (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Mar. 26, 2011
Patent Agreement, Net [Abstract]
 
Cash consideration received recorded as recovery of costs previously incurred
$ 4,000 
Stockholder's Equity (Details) (USD $)
In Millions, except Share data, unless otherwise specified
0 Months Ended 12 Months Ended 17 Months Ended 0 Months Ended 12 Months Ended
Mar. 30, 2013
Mar. 31, 2012
Nov. 4, 2010
November 2010 Repurchase Program [Member]
Mar. 30, 2013
November 2010 Repurchase Program [Member]
Mar. 31, 2012
November 2010 Repurchase Program [Member]
Mar. 31, 2012
November 2010 Repurchase Program [Member]
Nov. 20, 2012
November 2012 Repurchase Program [Member]
Mar. 30, 2013
November 2012 Repurchase Program [Member]
Mar. 30, 2013
Series A Participating Preferred Stock [Member]
Share repurchase program, amount approved
 
 
$ 80 
 
 
 
$ 200 
 
 
Shares repurchased
 
 
 
 
5,100,000 
 
 
3,000,000 
 
Shares repurchased, value
 
 
 
 
79.5 
 
 
86.1 
 
Average cost per share repurchased
 
 
 
 
 
$ 15.51 
 
$ 28.59 
 
Remaining amount available for share repurchases under stock repurchase program
 
 
 
$ 0.5 
 
 
 
$ 114.4 
 
Preferred Stock, shares authorized
5,000,000 
5,000,000 
 
 
 
 
 
 
5,000,000 
Preferred Stock, shares issued
 
 
 
 
 
 
 
 
Accumulated Other Comprehensive Loss (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Mar. 30, 2013
Mar. 31, 2012
Accumulated Other Comprehensive Loss [Abstract]
 
 
Beginning balance, accumulated other comprehensive loss
$ (762)
$ (754)
Beginning balance, foreign currency
(770)
(770)
Ending balance, accumulated other comprehensive loss
(919)
(762)
Ending balance, foreign currency
(770)
(770)
Beginning balance, unrealized gains (losses) on securities
16 
Ending balance, unrealized gains (losses) on securities
(149)
Current-period activity, unrealized gains (losses) on foreign currency
Current-period activity, unrealized gains (losses) on securities
(157)
(8)
Current-period activity, other comprehensive income
$ (157)
$ (8)
Income Taxes (Narrative) (Details) (USD $)
3 Months Ended 12 Months Ended
Mar. 31, 2012
Mar. 30, 2013
Mar. 31, 2012
Mar. 26, 2011
Income Taxes [Line Items]
 
 
 
 
Decrease in valuation allowance
 
$ 5,800,000 
$ 39,300,000 
 
Federal net operating loss carryforwards
 
177,100,000 
 
 
Net operating loss included in deferred tax assets
105,220,000 
28,162,000 
105,220,000 
 
Tax effected deferred tax asset
 
19,900,000 
 
 
Excess stock deductions
 
120,300,000 
 
 
Undistributed earnings in non-U.S subsidiaries
 
228,000 
 
 
Unrecognized deferred tax liability
 
81,000 
 
 
Provision (benefit) for income taxes
39,500,000 
64,592,000 
(8,000,000)
(119,289,000)
Federal [Member]
 
 
 
 
Income Taxes [Line Items]
 
 
 
 
Net operating loss included in deferred tax assets
 
56,800,000 
 
 
Section 382 Of Internal Revenue Code [Member]
 
 
 
 
Income Taxes [Line Items]
 
 
 
 
Net operating loss included in deferred tax assets
 
20,900,000 
 
 
Non-U.S [Member]
 
 
 
 
Income Taxes [Line Items]
 
 
 
 
Net operating loss carryforwards
 
2,000,000 
 
 
State [Member]
 
 
 
 
Income Taxes [Line Items]
 
 
 
 
Net operating loss carryforwards
 
101,600,000 
 
 
Maximum [Member] |
Federal [Member]
 
 
 
 
Income Taxes [Line Items]
 
 
 
 
Net operating loss carryforward expirations
 
2033 
 
 
Maximum [Member] |
State [Member]
 
 
 
 
Income Taxes [Line Items]
 
 
 
 
Net operating loss carryforward expirations
 
2029 
 
 
Minimum [Member] |
Federal [Member]
 
 
 
 
Income Taxes [Line Items]
 
 
 
 
Net operating loss carryforward expirations
 
2019 
 
 
Minimum [Member] |
State [Member]
 
 
 
 
Income Taxes [Line Items]
 
 
 
 
Net operating loss carryforward expirations
 
2014 
 
 
Research Tax Credit Carryforward [Member] |
Federal [Member]
 
 
 
 
Income Taxes [Line Items]
 
 
 
 
Tax credit carryforward
 
22,500,000 
 
 
Provision (benefit) for income taxes
 
(4,200,000)
 
 
Research Tax Credit Carryforward [Member] |
State [Member]
 
 
 
 
Income Taxes [Line Items]
 
 
 
 
Tax credit carryforward
 
14,500,000 
 
 
Tax credit carryforward subject to expiration
 
2,800,000 
 
 
Tax credit carryforward not subject to expiration
 
$ 11,700,000 
 
 
Research Tax Credit Carryforward [Member] |
Maximum [Member] |
Federal [Member]
 
 
 
 
Income Taxes [Line Items]
 
 
 
 
Net operating loss carryforward expirations
 
2033 
 
 
Research Tax Credit Carryforward [Member] |
Maximum [Member] |
State [Member]
 
 
 
 
Income Taxes [Line Items]
 
 
 
 
Net operating loss carryforward expirations
 
2027 
 
 
Research Tax Credit Carryforward [Member] |
Minimum [Member] |
Federal [Member]
 
 
 
 
Income Taxes [Line Items]
 
 
 
 
Net operating loss carryforward expirations
 
2014 
 
 
Research Tax Credit Carryforward [Member] |
Minimum [Member] |
State [Member]
 
 
 
 
Income Taxes [Line Items]
 
 
 
 
Net operating loss carryforward expirations
 
2022 
 
 
Income Taxes (Summary Of Income Before Income Taxes) (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Mar. 30, 2013
Mar. 31, 2012
Mar. 26, 2011
Income Taxes [Abstract]
 
 
 
United States
$ 200,124 
$ 79,425 
$ 83,569 
Non-U.S.
1,066 
558 
645 
Income before income taxes
$ 201,190 
$ 79,983 
$ 84,214 
Income Taxes (Summary Of Provision (Benefit) For Income Taxes) (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended
Mar. 31, 2012
Mar. 30, 2013
Mar. 31, 2012
Mar. 26, 2011
Income Taxes [Line Items]
 
 
 
 
Total current tax provision
 
$ 4,103 
$ 2,101 
$ 679 
Total deferred tax provision (benefit)
 
60,489 
(10,101)
(119,968)
Provision for income taxes
39,500 
64,592 
(8,000)
(119,289)
Federal [Member]
 
 
 
 
Income Taxes [Line Items]
 
 
 
 
Total current tax provision
 
3,537 
1,322 
163 
U.S [Member]
 
 
 
 
Income Taxes [Line Items]
 
 
 
 
Total deferred tax provision (benefit)
 
60,506 
(10,102)
(120,057)
State [Member]
 
 
 
 
Income Taxes [Line Items]
 
 
 
 
Total current tax provision
 
323 
518 
312 
Non-U.S [Member]
 
 
 
 
Income Taxes [Line Items]
 
 
 
 
Total current tax provision
 
243 
261 
204 
Total deferred tax provision (benefit)
 
$ (17)
$ 1 
$ 89 
Income Taxes (Summary Of Provision (Benefit) For Income Taxes, Statutory Federal Rate Pretax Income Reconciliation) (Details)
12 Months Ended
Mar. 30, 2013
Mar. 31, 2012
Mar. 26, 2011
Income Taxes [Abstract]
 
 
 
Expected income tax provision at the U.S. federal statutory rate
35.00% 
35.00% 
35.00% 
Valuation allowance changes affecting the provision of income taxes
(1.30%)
(46.70%)
(178.60%)
Foreign taxes at different rates
(0.10%)
 
0.10% 
R&D credit
(2.10%)
 
 
Stock compensation
0.10% 
1.00% 
(0.10%)
Nondeductible expenses
0.30% 
0.10% 
1.10% 
Other
0.20% 
0.60% 
0.90% 
Provision (benefit) for income taxes
32.10% 
(10.00%)
(141.60%)
Income Taxes (Significant Components Of Deferred Tax Assets And Liabilities) (Details) (USD $)
In Thousands, unless otherwise specified
Mar. 30, 2013
Mar. 31, 2012
Deferred tax assets:
 
 
Inventory valuation
$ 12,065 
$ 3,240 
Accrued expenses and allowances
5,077 
3,656 
Net operating loss carryforwards
28,162 
105,220 
Research and development tax credit carryforwards
37,054 
36,032 
State tax credit carryforwards
237 
244 
Capitalized research and development
6,601 
9,779 
Other
21,505 
18,747 
Total deferred tax assets
110,701 
176,918 
Valuation allowance for deferred tax assets
(23,232)
(29,075)
Net deferred tax assets
87,469 
147,843 
Deferred tax liabilities:
 
 
Depreciation and amortization
5,238 
287 
Acquisition intangibles
623 
5,348 
Total deferred tax liabilities
5,861 
5,635 
Total net deferred tax assets
$ 81,608 
$ 142,208 
Income Taxes (Summary Of Deferred Tax Assets) (Details) (USD $)
In Thousands, unless otherwise specified
Mar. 30, 2013
Mar. 31, 2012
Income Taxes [Abstract]
 
 
Current deferred tax assets
$ 64,937 
$ 53,137 
Long-term deferred tax assets
16,671 
89,071 
Total net deferred tax assets
$ 81,608 
$ 142,208 
Income Taxes (Reconciliation Of Unrecognized Tax Benefits) (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Mar. 30, 2013
Income Taxes [Abstract]
 
Balance
$ 0 
Additions based on tax positions related to the current year
Reductions for tax positions of prior years
Settlements
Reductions related to expirations of statutes of limitation
Balance
$ 0 
Segment Information (Narrative) (Details)
12 Months Ended
Mar. 30, 2013
segment
Segment Information [Abstract]
 
Number of reportable segments
Segment Information (Schedule Of Segment Revenue From Product Lines) (Details) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Mar. 30, 2013
Mar. 31, 2012
Mar. 26, 2011
Segment Reporting Information [Line Items]
 
 
 
Product revenue
$ 809,786 
$ 426,843 
$ 369,571 
Audio Products [Member]
 
 
 
Segment Reporting Information [Line Items]
 
 
 
Product revenue
754,769 
350,743 
264,840 
Energy Products [Member]
 
 
 
Segment Reporting Information [Line Items]
 
 
 
Product revenue
$ 55,017 
$ 76,100 
$ 104,731 
Segment Information (Schedule Of Sales By Geographic Location Based On The Sales Office Location) (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended
Mar. 30, 2013
Dec. 29, 2012
Sep. 29, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 24, 2011
Jun. 25, 2011
Mar. 30, 2013
Mar. 31, 2012
Mar. 26, 2011
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
 
 
 
 
 
 
 
 
 
Net sales
$ 206,873 
$ 310,133 
$ 193,774 
$ 99,006 
$ 110,631 1
$ 122,368 
$ 101,602 
$ 92,242 
$ 809,786 
$ 426,843 
$ 369,571 
United States [Member]
 
 
 
 
 
 
 
 
 
 
 
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
 
 
 
 
 
 
 
 
 
Net sales
 
 
 
 
 
 
 
 
38,670 
50,230 
66,701 
United Kingdom [Member]
 
 
 
 
 
 
 
 
 
 
 
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
 
 
 
 
 
 
 
 
 
Net sales
 
 
 
 
 
 
 
 
19,211 
23,927 
27,398 
China [Member]
 
 
 
 
 
 
 
 
 
 
 
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
 
 
 
 
 
 
 
 
 
Net sales
 
 
 
 
 
 
 
 
700,051 
294,143 
205,775 
Hong Kong [Member]
 
 
 
 
 
 
 
 
 
 
 
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
 
 
 
 
 
 
 
 
 
Net sales
 
 
 
 
 
 
 
 
8,590 
8,671 
9,216 
Japan [Member]
 
 
 
 
 
 
 
 
 
 
 
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
 
 
 
 
 
 
 
 
 
Net sales
 
 
 
 
 
 
 
 
9,299 
15,196 
16,902 
South Korea [Member]
 
 
 
 
 
 
 
 
 
 
 
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
 
 
 
 
 
 
 
 
 
Net sales
 
 
 
 
 
 
 
 
8,975 
9,781 
12,413 
Taiwan [Member]
 
 
 
 
 
 
 
 
 
 
 
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
 
 
 
 
 
 
 
 
 
Net sales
 
 
 
 
 
 
 
 
11,694 
10,662 
13,073 
Other Asia [Member]
 
 
 
 
 
 
 
 
 
 
 
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
 
 
 
 
 
 
 
 
 
Net sales
 
 
 
 
 
 
 
 
10,387 
13,063 
16,012 
Other Non-U.S. Countries [Member]
 
 
 
 
 
 
 
 
 
 
 
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
 
 
 
 
 
 
 
 
 
Net sales
 
 
 
 
 
 
 
 
$ 2,909 
$ 1,170 
$ 2,081 
Segment Information (Schedule Of Property, Plant, And Equipment, Net, By Geographic Location) (Details) (USD $)
In Thousands, unless otherwise specified
Mar. 30, 2013
Mar. 31, 2012
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
Property and equipment, net
$ 100,623 
$ 66,978 
United States [Member]
 
 
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
Property and equipment, net
100,343 
66,530 
United Kingdom [Member]
 
 
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
Property and equipment, net
23 
20 
China [Member]
 
 
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
Property and equipment, net
137 
158 
Hong Kong [Member]
 
 
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
Property and equipment, net
Japan [Member]
 
 
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
Property and equipment, net
25 
167 
South Korea [Member]
 
 
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
Property and equipment, net
Taiwan [Member]
 
 
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
Property and equipment, net
70 
83 
Other Asia [Member]
 
 
Revenues from External Customers and Long-Lived Assets [Line Items]
 
 
Property and equipment, net
$ 14 
$ 11 
Quarterly Results (Unaudited) (Schedule Of Unaudited Quarterly Statement Of Operations Data) (Details) (USD $)
3 Months Ended 12 Months Ended
Mar. 30, 2013
Dec. 29, 2012
Sep. 29, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 24, 2011
Jun. 25, 2011
Mar. 30, 2013
Mar. 31, 2012
Mar. 26, 2011
Quarterly Results (Unaudited) [Abstract]
 
 
 
 
 
 
 
 
 
 
 
Net sales
$ 206,873,000 
$ 310,133,000 
$ 193,774,000 
$ 99,006,000 
$ 110,631,000 1
$ 122,368,000 
$ 101,602,000 
$ 92,242,000 
$ 809,786,000 
$ 426,843,000 
$ 369,571,000 
Gross margin
83,614,000 
158,050,000 
100,087,000 
53,440,000 
62,347,000 1
66,030,000 
54,355,000 
47,709,000 
395,191,000 
230,441,000 
201,995,000 
Net income
26,360,000 
67,862,000 
35,449,000 
6,927,000 
50,827,000 1
16,731,000 
11,247,000 
9,178,000 
136,598,000 
87,983,000 
203,503,000 
Basic income per share
$ 0.41 
$ 1.04 
$ 0.55 
$ 0.11 
$ 0.79 1
$ 0.26 
$ 0.17 
$ 0.14 
$ 2.12 
$ 1.35 
$ 3.00 
Diluted income per share
$ 0.39 
$ 0.99 
$ 0.51 
$ 0.10 
$ 0.75 1
$ 0.25 
$ 0.17 
$ 0.13 
$ 2.00 
$ 1.29 
$ 2.82 
Income tax benefit
 
 
 
 
39,500,000 
 
 
 
64,592,000 
(8,000,000)
(119,289,000)
Decrease in valuation allowance on deferred tax assets
 
 
 
 
$ 37,300,000